Gut-liver axis: Pathophysiological concepts and clinical implications
Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial co...
Saved in:
| Published in | Cell metabolism Vol. 34; no. 11; pp. 1700 - 1718 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.11.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial community structure and function. Perturbation of such host-microbe interactions is observed in a variety of experimental liver diseases and is facilitated by an impaired intestinal barrier, which is fueling hepatic inflammation and disease progression. Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a common sequela of these diseases, the intestinal microbiota and microbial pathogen-associated molecular patterns constitute liver inflammation and clinical complications, such as hepatic encephalopathy. Understanding the intricate metabolic interplay between the gut and liver in health and disease opens an avenue for targeted therapies in the future, which is probed in controlled clinical trials.
Tilg et al. discuss experimental and clinical aspects of the bidirectional gut-liver crosstalk in health and how perturbation of such inter-organ communication promotes liver diseases. Collectively, the diet, gut mucosal immunity and related microbial commensalism, and hepatic metabolism shape the communication along the gut-liver axis, fueling various liver diseases. |
|---|---|
| AbstractList | Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial community structure and function. Perturbation of such host-microbe interactions is observed in a variety of experimental liver diseases and is facilitated by an impaired intestinal barrier, which is fueling hepatic inflammation and disease progression. Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a common sequela of these diseases, the intestinal microbiota and microbial pathogen-associated molecular patterns constitute liver inflammation and clinical complications, such as hepatic encephalopathy. Understanding the intricate metabolic interplay between the gut and liver in health and disease opens an avenue for targeted therapies in the future, which is probed in controlled clinical trials. Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial community structure and function. Perturbation of such host-microbe interactions is observed in a variety of experimental liver diseases and is facilitated by an impaired intestinal barrier, which is fueling hepatic inflammation and disease progression. Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a common sequela of these diseases, the intestinal microbiota and microbial pathogen-associated molecular patterns constitute liver inflammation and clinical complications, such as hepatic encephalopathy. Understanding the intricate metabolic interplay between the gut and liver in health and disease opens an avenue for targeted therapies in the future, which is probed in controlled clinical trials.Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial community structure and function. Perturbation of such host-microbe interactions is observed in a variety of experimental liver diseases and is facilitated by an impaired intestinal barrier, which is fueling hepatic inflammation and disease progression. Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a common sequela of these diseases, the intestinal microbiota and microbial pathogen-associated molecular patterns constitute liver inflammation and clinical complications, such as hepatic encephalopathy. Understanding the intricate metabolic interplay between the gut and liver in health and disease opens an avenue for targeted therapies in the future, which is probed in controlled clinical trials. Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients, microbial antigens, metabolites, and bile acids regulate metabolism and immune responses in the gut and liver, which reciprocally shape microbial community structure and function. Perturbation of such host-microbe interactions is observed in a variety of experimental liver diseases and is facilitated by an impaired intestinal barrier, which is fueling hepatic inflammation and disease progression. Clinical evidence describes perturbation of the gut-liver crosstalk in non-alcoholic fatty liver disease, alcoholic liver disease, and primary sclerosing cholangitis. In liver cirrhosis, a common sequela of these diseases, the intestinal microbiota and microbial pathogen-associated molecular patterns constitute liver inflammation and clinical complications, such as hepatic encephalopathy. Understanding the intricate metabolic interplay between the gut and liver in health and disease opens an avenue for targeted therapies in the future, which is probed in controlled clinical trials. Tilg et al. discuss experimental and clinical aspects of the bidirectional gut-liver crosstalk in health and how perturbation of such inter-organ communication promotes liver diseases. Collectively, the diet, gut mucosal immunity and related microbial commensalism, and hepatic metabolism shape the communication along the gut-liver axis, fueling various liver diseases. |
| Author | Adolph, Timon E. Trauner, Michael Tilg, Herbert |
| Author_xml | – sequence: 1 givenname: Herbert surname: Tilg fullname: Tilg, Herbert email: herbert.tilg@i-med.ac.at organization: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University, Innsbruck, Austria – sequence: 2 givenname: Timon E. surname: Adolph fullname: Adolph, Timon E. organization: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University, Innsbruck, Austria – sequence: 3 givenname: Michael surname: Trauner fullname: Trauner, Michael organization: Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University, Vienna, Austria |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36208625$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kLtOwzAUQC1URMvjBxhQRpYEP_IyYkGoPCQkGGC2jHNDXTlxsF1E_x6HFgaGTr6yzrF8zyGa9LYHhE4Jzggm5cUyUx2EjGJKM8wzTKo9NCOc0bTKKZ7EuShwmhNGpujQ-yXGrGScHaApKymuS1rM0PxuFVKjP8El8kv7y-RZhoUdFmuvrbHvWkmTKNsrGIJPZN8kyuj-51Z3g4lD0Lb3x2i_lcbDyfY8Qq-385eb-_Tx6e7h5voxVTmlIeV109KCQwmy4bxSVDJVMV4Tkrcsr6GmTY15i5mqW0KqEZfyreVUjt9VJTtC55t3B2c_VuCD6LRXYIzswa68oBVlpMS4KiJ6tkVXbx00YnC6k24tflePAN0AylnvHbR_CMFi7CuWYuwrxr4CcxH7Rqn-JykdfhoEJ7XZrV5tVIiBPjU44ZWGWLbRDlQQjdW79G_dQZWu |
| CitedBy_id | crossref_primary_10_1016_j_fbio_2023_103335 crossref_primary_10_1016_j_scitotenv_2024_174710 crossref_primary_10_17816_EID451025 crossref_primary_10_1016_j_bbadis_2024_167571 crossref_primary_10_1016_j_scitotenv_2023_169642 crossref_primary_10_1016_j_bbalip_2024_159535 crossref_primary_10_1097_HC9_0000000000000241 crossref_primary_10_1186_s12964_024_01720_9 crossref_primary_10_1016_j_envpol_2024_124933 crossref_primary_10_3390_ijms25147621 crossref_primary_10_1016_j_ejphar_2024_176773 crossref_primary_10_1016_j_intimp_2024_113173 crossref_primary_10_1186_s10020_024_00830_x crossref_primary_10_1016_j_biopha_2024_116724 crossref_primary_10_1016_j_ijbiomac_2024_132251 crossref_primary_10_1016_j_jcmgh_2023_10_012 crossref_primary_10_1111_his_15006 crossref_primary_10_3390_ph17091149 crossref_primary_10_1016_j_foodres_2025_116178 crossref_primary_10_4014_jmb_2405_05023 crossref_primary_10_3389_fmicb_2023_1344969 crossref_primary_10_1016_j_dld_2023_11_023 crossref_primary_10_1016_j_jff_2024_106247 crossref_primary_10_1016_j_ejphar_2024_177172 crossref_primary_10_1097_HEP_0000000000000386 crossref_primary_10_1080_19490976_2024_2351620 crossref_primary_10_3389_fimmu_2023_1192840 crossref_primary_10_3748_wjg_v29_i22_3400 crossref_primary_10_1039_D3FO03572G crossref_primary_10_3389_fnut_2023_1155306 crossref_primary_10_1080_19490976_2024_2307586 crossref_primary_10_1007_s11154_023_09820_6 crossref_primary_10_1186_s10020_024_01022_3 crossref_primary_10_3389_fcimb_2023_1152987 crossref_primary_10_1111_jgh_16359 crossref_primary_10_3389_fphar_2024_1432480 crossref_primary_10_3390_ph18040451 crossref_primary_10_3389_fcell_2022_1089124 crossref_primary_10_1111_eci_14224 crossref_primary_10_1016_j_jcmgh_2024_04_009 crossref_primary_10_3390_biomedicines13010074 crossref_primary_10_1097_CLD_0000000000000131 crossref_primary_10_3390_nu16152551 crossref_primary_10_1016_j_yexcr_2025_114518 crossref_primary_10_3390_pathogens14010002 crossref_primary_10_1097_PPO_0000000000000646 crossref_primary_10_31146_1682_8658_ecg_226_6_63_69 crossref_primary_10_1016_S2468_1253_23_00159_0 crossref_primary_10_3389_fnagi_2025_1501319 crossref_primary_10_3390_nu16050600 crossref_primary_10_1016_j_clnesp_2023_11_009 crossref_primary_10_1186_s12920_024_01939_y crossref_primary_10_4251_wjgo_v15_i5_713 crossref_primary_10_1016_j_freeradbiomed_2024_08_037 crossref_primary_10_3390_nu15133033 crossref_primary_10_1016_j_jhepr_2024_101234 crossref_primary_10_1172_jci_insight_186649 crossref_primary_10_3390_foods13182992 crossref_primary_10_1016_j_ecoenv_2024_116147 crossref_primary_10_1016_j_ecoenv_2024_116388 crossref_primary_10_3390_biomedicines13040779 crossref_primary_10_1002_mbo3_1434 crossref_primary_10_1097_HC9_0000000000000572 crossref_primary_10_1016_j_biopha_2024_117240 crossref_primary_10_3390_ijms241814191 crossref_primary_10_3389_fmicb_2024_1518150 crossref_primary_10_3390_ijms25147873 crossref_primary_10_1021_acs_jafc_3c04832 crossref_primary_10_1080_19490976_2024_2399260 crossref_primary_10_1007_s00198_024_07217_y crossref_primary_10_1016_j_scitotenv_2023_167317 crossref_primary_10_1016_j_envpol_2023_122238 crossref_primary_10_3390_ani13101659 crossref_primary_10_3390_cells12141888 crossref_primary_10_3350_cmh_2024_0359 crossref_primary_10_3390_microorganisms11030597 crossref_primary_10_1161_ATVBAHA_123_318980 crossref_primary_10_3390_microorganisms12030463 crossref_primary_10_29254_2077_4214_2024_3_174_76_86 crossref_primary_10_1136_gutjnl_2024_331914 crossref_primary_10_3390_diagnostics14151606 crossref_primary_10_1002_brb3_70222 crossref_primary_10_1007_s00204_023_03536_x crossref_primary_10_3390_medicina61020192 crossref_primary_10_1186_s12876_024_03162_6 crossref_primary_10_1016_j_biopha_2024_116760 crossref_primary_10_1111_liv_70059 crossref_primary_10_3390_jox14040086 crossref_primary_10_1016_j_jhazmat_2024_135952 crossref_primary_10_3389_fendo_2024_1434338 crossref_primary_10_3389_fphar_2024_1347120 crossref_primary_10_1021_acs_jafc_4c09209 crossref_primary_10_3390_biomedicines11010143 crossref_primary_10_3389_fcimb_2024_1371429 crossref_primary_10_1096_fj_202301126 crossref_primary_10_1016_j_imlet_2023_10_001 crossref_primary_10_1016_j_phrs_2024_107334 crossref_primary_10_1016_j_scitotenv_2024_170962 crossref_primary_10_1631_jzus_B2200439 crossref_primary_10_1016_j_heliyon_2024_e27819 crossref_primary_10_1016_j_smim_2023_101859 crossref_primary_10_1186_s13071_024_06245_1 crossref_primary_10_1146_annurev_pathmechdis_051122_094743 crossref_primary_10_3390_cimb46070399 crossref_primary_10_3389_fmicb_2023_1169811 crossref_primary_10_1016_j_biopha_2024_116658 crossref_primary_10_3390_antiox13060729 crossref_primary_10_1016_j_carbpol_2023_121565 crossref_primary_10_1016_j_foodres_2024_114489 crossref_primary_10_1021_acsnano_5c00325 crossref_primary_10_1016_j_bbrc_2024_150445 crossref_primary_10_1002_1873_3468_15072 crossref_primary_10_1016_j_psj_2024_104422 crossref_primary_10_3389_fmicb_2024_1495170 crossref_primary_10_1016_j_livres_2023_07_002 crossref_primary_10_12677_acm_2025_153639 crossref_primary_10_1039_D4FO03809F crossref_primary_10_1016_j_jare_2024_03_004 crossref_primary_10_3389_fmicb_2024_1403316 crossref_primary_10_3389_fmicb_2024_1342356 crossref_primary_10_1038_s42255_024_01156_y crossref_primary_10_1016_j_ecoenv_2025_118042 crossref_primary_10_1016_j_tox_2025_154105 crossref_primary_10_1038_s41576_023_00674_x crossref_primary_10_1038_s41598_025_92618_0 crossref_primary_10_1016_j_livres_2025_01_001 crossref_primary_10_1002_ppul_26869 crossref_primary_10_3389_fmicb_2023_1256874 crossref_primary_10_1016_j_ecoenv_2023_115887 crossref_primary_10_1016_j_jff_2024_106390 crossref_primary_10_1016_j_phymed_2025_156369 crossref_primary_10_3389_fcimb_2024_1402329 crossref_primary_10_1080_10408398_2023_2272269 crossref_primary_10_1016_j_chroma_2024_465619 crossref_primary_10_1016_j_bbrc_2024_149690 crossref_primary_10_3389_fcimb_2024_1411843 crossref_primary_10_3390_livers4040044 crossref_primary_10_1007_s12072_024_10662_w crossref_primary_10_1016_j_apsb_2024_07_026 crossref_primary_10_1016_j_fitote_2024_106186 crossref_primary_10_3390_biom14010059 crossref_primary_10_1016_j_ebiom_2024_105482 crossref_primary_10_1186_s13099_023_00549_w crossref_primary_10_1080_14728222_2023_2274099 crossref_primary_10_1016_j_intimp_2024_112895 crossref_primary_10_1039_D4FO05325G crossref_primary_10_1097_HC9_0000000000000491 crossref_primary_10_71150_jm_2411002 crossref_primary_10_3389_fmicb_2023_1255650 crossref_primary_10_1016_j_ecoenv_2023_115637 crossref_primary_10_3390_ijms252413386 crossref_primary_10_1016_j_phymed_2025_156495 crossref_primary_10_3389_fphar_2024_1408459 crossref_primary_10_1021_acs_nanolett_3c04548 crossref_primary_10_1016_j_jia_2024_05_014 crossref_primary_10_1051_parasite_2025011 crossref_primary_10_4254_wjh_v16_i5_822 crossref_primary_10_1016_j_ijbiomac_2025_141660 crossref_primary_10_1021_acs_jafc_4c05163 crossref_primary_10_1016_j_jhep_2023_03_038 crossref_primary_10_3389_fendo_2024_1442603 crossref_primary_10_3390_md23030134 crossref_primary_10_1016_j_envres_2024_119442 crossref_primary_10_1002_ctm2_70035 crossref_primary_10_1016_j_intimp_2024_113570 crossref_primary_10_1016_j_hlife_2025_01_001 crossref_primary_10_1124_dmd_123_001604 crossref_primary_10_1128_spectrum_01979_23 crossref_primary_10_1080_14737140_2023_2262765 crossref_primary_10_3390_ijms25041988 crossref_primary_10_1038_s41421_023_00578_4 crossref_primary_10_3389_fmicb_2024_1414486 crossref_primary_10_1016_j_jceh_2024_101455 crossref_primary_10_1142_S0192415X24500149 crossref_primary_10_3390_microorganisms12081678 crossref_primary_10_1038_s41575_022_00741_4 crossref_primary_10_1007_s11427_024_2722_2 crossref_primary_10_3390_ijms242216502 crossref_primary_10_5582_bst_2024_01097 crossref_primary_10_1016_j_cmet_2024_08_012 crossref_primary_10_1002_jgh3_13018 crossref_primary_10_1016_j_copbio_2024_103248 crossref_primary_10_3390_metabo13070859 crossref_primary_10_1016_j_tem_2024_06_003 crossref_primary_10_1016_j_foodres_2024_114205 crossref_primary_10_1080_00365521_2023_2286190 crossref_primary_10_3389_fimmu_2024_1500863 crossref_primary_10_3389_fimmu_2024_1330021 crossref_primary_10_1016_j_clinre_2024_102478 crossref_primary_10_3748_wjg_v30_i41_4461 crossref_primary_10_1016_j_foodres_2024_114682 crossref_primary_10_1080_19490976_2024_2390164 crossref_primary_10_1007_s11011_025_01554_5 crossref_primary_10_1080_19490976_2024_2370634 crossref_primary_10_1080_19490976_2024_2367342 crossref_primary_10_12677_ACM_2022_12111557 crossref_primary_10_12677_ACM_2024_141067 crossref_primary_10_22328_2413_5747_2023_9_3_24_39 crossref_primary_10_1016_j_envpol_2023_122895 crossref_primary_10_1016_j_ecoenv_2024_116538 crossref_primary_10_1016_j_ecoenv_2024_116537 crossref_primary_10_1111_apt_18119 crossref_primary_10_3390_microorganisms12061110 crossref_primary_10_1007_s10753_024_02021_6 crossref_primary_10_1097_HEP_0000000000001160 crossref_primary_10_1155_2024_8882667 crossref_primary_10_1186_s40104_023_00982_6 crossref_primary_10_1016_j_envint_2025_109360 crossref_primary_10_1002_mco2_721 crossref_primary_10_1038_s41564_023_01440_9 crossref_primary_10_1002_mnfr_202200821 crossref_primary_10_3389_fimmu_2024_1336493 crossref_primary_10_1038_s41574_023_00898_1 crossref_primary_10_1080_07420528_2023_2207649 crossref_primary_10_3390_genes15080970 crossref_primary_10_1016_j_isci_2024_108861 crossref_primary_10_1016_j_jep_2023_116950 crossref_primary_10_1016_j_carbpol_2024_123022 crossref_primary_10_12944_CRNFSJ_12_2_2 crossref_primary_10_3390_antiox12071355 crossref_primary_10_1142_S0192415X24500046 crossref_primary_10_1136_gutjnl_2024_333378 crossref_primary_10_3390_biomedicines12122781 crossref_primary_10_1016_j_ecoenv_2024_117512 crossref_primary_10_1016_j_jhep_2024_09_032 crossref_primary_10_3389_fcell_2025_1563184 crossref_primary_10_1016_S2213_8587_23_00154_7 crossref_primary_10_1111_iej_14119 crossref_primary_10_23736_S2724_542X_24_03196_1 crossref_primary_10_20517_mrr_2023_44 crossref_primary_10_1016_j_aquaculture_2024_741752 crossref_primary_10_1038_s41598_024_74023_1 crossref_primary_10_1111_jgh_16737 crossref_primary_10_1016_j_jff_2024_106506 crossref_primary_10_1097_HC9_0000000000000615 crossref_primary_10_1186_s11658_024_00603_8 crossref_primary_10_3389_fcimb_2023_1128249 crossref_primary_10_1016_j_clinre_2024_102458 crossref_primary_10_1152_ajpgi_00167_2024 crossref_primary_10_1016_j_aninu_2024_09_003 crossref_primary_10_1186_s12951_025_03259_4 crossref_primary_10_1016_j_fbio_2024_104469 crossref_primary_10_1016_j_engreg_2024_04_003 crossref_primary_10_1097_MEG_0000000000002934 crossref_primary_10_1016_j_ecoenv_2024_116832 crossref_primary_10_1002_mco2_70012 crossref_primary_10_11569_wcjd_v31_i21_889 crossref_primary_10_3389_fnut_2023_1121203 crossref_primary_10_1016_j_scitotenv_2024_173384 crossref_primary_10_3390_jcm13030919 crossref_primary_10_7554_eLife_93273 crossref_primary_10_1016_j_ijbiomac_2025_139514 crossref_primary_10_1016_j_phymed_2024_156272 crossref_primary_10_3389_fmicb_2023_1290246 crossref_primary_10_2147_JIR_S478568 crossref_primary_10_3389_fimmu_2024_1454334 crossref_primary_10_1002_bmc_70040 crossref_primary_10_3389_fnins_2023_1327499 crossref_primary_10_1002_imt2_70004 crossref_primary_10_1016_j_actbio_2024_09_012 crossref_primary_10_1016_j_jhepr_2024_101188 crossref_primary_10_1007_s44154_024_00178_6 crossref_primary_10_3390_metabo14070366 crossref_primary_10_1016_j_dld_2024_11_002 crossref_primary_10_1039_D4FO03077J crossref_primary_10_3390_ijms241914918 crossref_primary_10_3389_fmicb_2024_1407991 crossref_primary_10_1038_s41575_023_00807_x crossref_primary_10_1016_j_toxrep_2025_101955 crossref_primary_10_7554_eLife_93273_3 crossref_primary_10_1007_s10753_024_02184_2 crossref_primary_10_1136_gutjnl_2022_328853 crossref_primary_10_1016_j_micpath_2023_106265 crossref_primary_10_3390_nu15092150 crossref_primary_10_1016_j_jep_2024_118804 crossref_primary_10_1007_s13205_024_04180_7 crossref_primary_10_1186_s12876_024_03277_w crossref_primary_10_3389_fnut_2025_1478542 crossref_primary_10_1080_1744666X_2023_2294046 crossref_primary_10_1016_j_biopha_2023_115410 crossref_primary_10_3389_fmicb_2024_1376757 crossref_primary_10_1007_s00535_024_02134_7 crossref_primary_10_1080_10408398_2024_2390556 crossref_primary_10_14336_AD_2023_0923 crossref_primary_10_1038_s41575_023_00771_6 crossref_primary_10_1016_j_bpg_2024_101945 crossref_primary_10_1186_s12964_023_01425_5 crossref_primary_10_3389_fimmu_2025_1544012 crossref_primary_10_1016_j_scitotenv_2024_177857 crossref_primary_10_1038_s41538_024_00334_2 crossref_primary_10_1016_j_cmet_2023_07_011 crossref_primary_10_3390_ijms242417606 crossref_primary_10_1038_s41572_025_00600_x crossref_primary_10_3389_fphar_2024_1337057 crossref_primary_10_1038_s41392_023_01673_4 crossref_primary_10_3390_cells14020084 crossref_primary_10_1111_liv_15663 crossref_primary_10_1007_s11377_025_00881_4 crossref_primary_10_1080_19490976_2023_2201157 crossref_primary_10_3390_nu15173722 crossref_primary_10_3390_biomedicines12092144 crossref_primary_10_3389_fmicb_2024_1442506 crossref_primary_10_3350_cmh_2024_0315 crossref_primary_10_4251_wjgo_v16_i4_1319 |
| Cites_doi | 10.1038/nri2653 10.1053/j.gastro.2009.08.042 10.1080/19490976.2020.1859812 10.1016/j.jhepr.2020.100151 10.1002/hep.22848 10.1073/pnas.1005963107 10.1016/j.cmet.2020.06.005 10.1038/s42255-022-00559-z 10.1126/science.abp9960 10.1097/MOG.0000000000000809 10.1016/j.jbiosc.2014.03.001 10.1016/j.cmet.2015.06.007 10.1053/j.gastro.2020.08.054 10.1038/s41564-021-00880-5 10.1016/j.cmet.2015.03.001 10.1038/s41586-021-03532-0 10.1038/srep19076 10.1016/j.cmet.2017.05.002 10.1016/j.chom.2020.07.014 10.1016/S0168-8278(87)80003-X 10.1016/j.cmet.2018.08.005 10.1136/gutjnl-2016-312137 10.1016/j.cell.2021.12.018 10.1136/gutjnl-2019-319664 10.1038/s41467-021-21461-4 10.1016/j.jhep.2013.01.003 10.1016/S0168-8278(00)80242-1 10.1172/JCI70710 10.1007/BF00454879 10.1038/s41586-020-2425-3 10.1002/bjs.1800631011 10.1016/S0140-6736(21)01701-3 10.1016/j.diabet.2020.07.010 10.1097/MPG.0b013e3181c7bdf1 10.1053/jhep.2003.50116 10.1038/nm1501 10.1017/S0007114512005326 10.1111/apt.13333 10.1038/s41586-021-03663-4 10.1530/JOE-20-0018 10.1016/j.jnutbio.2015.05.011 10.1038/s41586-020-2881-9 10.1016/j.jhep.2018.10.035 10.1038/s41575-020-00376-3 10.1038/s41586-020-2396-4 10.1038/s41591-018-0061-3 10.1016/j.jhep.2019.09.029 10.1038/s41590-021-00867-8 10.1161/ATVBAHA.119.313414 10.1002/hep.28829 10.1016/j.cell.2016.05.041 10.1038/s41586-020-2101-7 10.1111/apt.14393 10.1016/j.cell.2018.07.048 10.1002/hep.28991 10.1136/gutjnl-2016-313432 10.1038/s41467-020-15068-4 10.1038/ncomms3384 10.1016/0016-5085(95)90206-6 10.1053/j.gastro.2020.02.033 10.1016/j.jhep.2021.03.020 10.1136/gutjnl-2020-322753 10.1080/19490976.2022.2029674 10.1016/j.ajpath.2021.12.008 10.1073/pnas.1712837114 10.1016/j.tem.2022.01.002 10.1002/hep.31560 10.1128/IAI.00719-20 10.1053/j.gastro.2016.08.057 10.1053/j.gastro.2018.08.022 10.1136/gutjnl-2020-321565 10.1136/gutjnl-2019-318811 10.1016/j.cell.2011.09.025 10.1002/hep.31417 10.1038/s41575-021-00440-6 10.1002/hep.32289 10.1038/s41586-019-1742-x 10.1126/science.aad0135 10.1053/j.gastro.2017.02.038 10.1038/s42255-020-0261-2 10.1053/j.gastro.2020.08.004 10.1038/s42255-021-00501-9 10.1016/j.jhep.2014.12.034 10.2337/db16-0663 10.3390/metabo12010041 10.1242/jcs.112.1.137 10.1017/cts.2021.801 10.1136/gutjnl-2018-316227 10.1016/j.jhep.2018.09.014 10.1111/apt.14540 10.1038/s42255-021-00452-1 10.1128/AEM.03004-19 10.1002/hep.31708 10.1016/j.jhepr.2020.100220 10.1016/0168-8278(91)90933-3 10.4049/jimmunol.166.7.4737 10.1002/hep.22771 10.1038/s41586-021-03832-5 10.1136/gutjnl-2021-326789 10.1038/s42255-019-0074-3 10.1152/ajpgi.00271.2021 10.1016/j.cell.2020.08.027 10.1126/science.1214914 10.1038/s41564-018-0333-1 10.1016/j.jhep.2015.02.023 10.1055/s-0037-1608801 10.1172/jci.insight.138881 10.1016/j.cmet.2021.05.004 10.1038/s41575-021-00523-4 10.1016/j.cmet.2022.03.001 10.1038/nature11225 10.1002/hep.30590 10.1038/s41591-019-0660-7 10.1016/j.mce.2022.111618 10.1038/s41574-018-0016-2 10.1002/hep.29857 10.3945/ajcn.2009.27792 10.1194/jlr.R900010-JLR200 10.1038/s41586-021-03671-4 10.1016/S0016-5085(19)32333-9 10.1007/164_2019_232 10.1038/s41591-018-0222-4 10.1073/pnas.0600780103 10.1016/j.jhep.2020.11.013 10.1016/S2468-1253(19)30184-0 10.1210/me.2010-0142 10.1053/jhep.2003.50182 10.1016/j.jhep.2016.12.005 10.2337/db07-1403 10.1126/scitranslmed.3000322 10.1016/j.jcmgh.2015.01.001 10.1053/j.gastro.2021.12.288 10.1172/JCI151725 10.3389/fmicb.2022.814692 10.1016/j.molcel.2020.03.001 10.1136/gutjnl-2020-320786 10.1136/gutjnl-2017-314307 10.1126/science.1208344 10.1194/jlr.R049437 10.1038/nrgastro.2016.154 10.1038/s41575-021-00566-7 10.1155/2020/6672636 10.1016/j.cmet.2016.05.005 10.1126/science.1239275 10.1038/s41586-019-1785-z 10.1053/j.gastro.2020.06.006 10.1002/hep.27489 10.1016/j.cell.2022.01.017 10.1136/gutjnl-2012-302945 10.1038/s41586-021-03241-8 10.1126/science.1241165 10.1038/s41591-019-0495-2 10.1016/j.isci.2021.103092 10.1016/j.jhep.2019.10.003 10.3389/fimmu.2018.01735 10.1002/hep.30832 10.1172/JCI113938 10.1016/j.jcmgh.2021.08.014 10.1074/jbc.M211609200 10.1096/fj.202101371R 10.1053/jhep.2001.25350 10.1038/nature14232 10.1038/nature12820 10.1016/j.cmet.2011.03.019 10.1158/0008-5472.CAN-14-0208 10.1038/nature13568 10.1038/nm1663 10.1056/NEJMoa1109400 10.1016/0140-6736(91)92725-H 10.1007/s12072-020-10070-w 10.1136/gutjnl-2020-323071 10.1002/hep.24423 10.1002/hep.27927 10.1080/19490976.2020.1851986 10.1016/j.chom.2018.05.012 10.1038/nm.3760 10.1016/j.chom.2018.03.011 10.1002/lt.25882 10.1126/science.aar3318 10.1111/joim.13157 10.1016/S0002-9440(10)61196-0 10.1055/s-0039-1688501 10.1126/science.1198719 10.1038/s41577-021-00529-8 10.1210/clinem/dgab578 10.4161/19490976.2014.990784 10.1111/1751-2980.12294 10.1038/s41577-019-0198-4 10.1016/j.jhep.2021.11.029 10.1038/s41586-019-1865-0 10.1038/s41586-020-2193-0 10.1038/s41586-020-2047-9 10.1007/s11695-007-9243-7 10.1038/s41467-021-27385-3 10.1016/j.cell.2019.07.050 10.1194/jlr.R500013-JLR200 10.1016/j.jsbmb.2012.04.008 10.1016/j.ccr.2011.01.040 10.1002/hep.30349 10.1111/apt.15148 10.4049/jimmunol.180.8.5653 10.1016/j.jhep.2019.08.005 10.1152/physrev.00049.2019 10.1016/j.cmet.2018.07.001 10.1016/j.cmet.2020.11.017 10.1073/pnas.0509592103 10.1016/j.cmet.2013.03.013 10.1016/j.cell.2016.02.011 10.1055/s-0041-1731707 10.1136/gutjnl-2019-318416 10.1038/nm.4412 10.1016/j.cmet.2017.04.001 10.1016/j.cmet.2018.09.003 10.1093/ajcn/86.5.1286 10.1016/j.jhep.2017.07.022 10.2337/db06-1491 10.1016/j.cmet.2021.09.004 10.1016/j.cell.2018.09.055 10.1126/science.abk0297 10.1053/j.gastro.2012.01.034 10.1038/s41586-022-04480-z 10.1053/j.gastro.2021.11.006 10.1016/j.jhep.2011.05.015 10.1016/j.cmet.2015.07.009 10.5009/gnl16510 10.1053/j.gastro.2014.01.020 10.1016/j.jhep.2020.01.011 10.1126/science.abe6729 10.1002/hep4.1209 10.1136/gut.39.4.587 10.1210/endo.143.5.8850 10.1073/pnas.1219451110 10.1111/liv.13979 10.1002/hep.29791 10.1016/j.celrep.2022.111008 10.1053/j.gastro.2020.10.056 10.3390/cells10113206 10.1136/gut.2004.046615 10.1038/s41575-021-00452-2 10.1136/gutjnl-2018-316670 10.1016/j.jcmgh.2020.09.008 10.1016/j.jhep.2019.06.017 10.1038/s41467-020-16274-w 10.1016/j.chom.2020.12.004 10.1038/s41467-022-28478-3 10.1016/j.ajpath.2014.10.009 10.14309/ajg.0000000000000115 10.1016/j.jhep.2015.12.010 10.1126/science.282.5396.2085 10.1002/hep.31056 10.1096/fj.201601365R 10.1053/j.gastro.2021.08.032 10.1016/j.neo.2021.04.004 10.1194/jlr.M800156-JLR200 10.1038/nature09922 10.1002/hep.30975 10.1002/hep.26939 10.1016/j.cmet.2016.06.009 10.1002/hep4.1740 10.1016/j.tem.2019.08.013 10.1053/j.gastro.2008.12.040 10.1038/nm.4236 10.1053/j.gastro.2020.01.050 10.1093/eurheartj/ehx342 10.1053/j.gastro.2020.12.058 10.1056/NEJMoa2028395 10.1053/j.gastro.2020.07.003 |
| ContentType | Journal Article |
| Copyright | 2022 Elsevier Inc. Copyright © 2022 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2022 Elsevier Inc. – notice: Copyright © 2022 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.cmet.2022.09.017 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1932-7420 |
| EndPage | 1718 |
| ExternalDocumentID | 36208625 10_1016_j_cmet_2022_09_017 S1550413122004077 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GrantInformation_xml | – fundername: Austrian Science Fund FWF grantid: P 33070 – fundername: Austrian Science Fund FWF grantid: P 29379 |
| GroupedDBID | --- --K 0R~ 1~5 29B 2WC 4.4 457 4G. 53G 5GY 62- 6J9 7-5 AACTN AAEDW AAFTH AAIAV AAKRW AAKUH AALRI AAUCE AAVLU AAXUO ABJNI ABMAC ABMWF ABVKL ACGFO ACGFS ADBBV ADEZE ADJPV AEFWE AENEX AEXQZ AFTJW AGKMS AITUG ALKID ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL CS3 DIK DU5 E3Z EBS F5P FCP FDB FEDTE FIRID HVGLF IHE IXB J1W JIG M3Z M41 O-L O9- OK1 P2P RCE ROL RPZ SES SSZ TR2 UNMZH WQ6 ZA5 AAEDT AAIKJ AAMRU AAYWO AAYXX ABDGV ACVFH ADCNI ADVLN AEUPX AFPUW AGCQF AGHFR AIGII AKAPO AKBMS AKRWK AKYEP APXCP CITATION EJD HZ~ OZT RIG CGR CUY CVF ECM EFKBS EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c422t-98df259e6ead997c2a3c7398114f348e82d809f03c8f11798dfaabf92a2086c63 |
| IEDL.DBID | IXB |
| ISSN | 1550-4131 1932-7420 |
| IngestDate | Fri Jul 11 15:31:52 EDT 2025 Mon Jul 21 06:08:01 EDT 2025 Tue Jul 01 03:58:20 EDT 2025 Thu Apr 24 23:03:58 EDT 2025 Fri Feb 23 02:39:45 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | gut microbiome liver disease gut-liver axis leaky gut |
| Language | English |
| License | Copyright © 2022 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c422t-98df259e6ead997c2a3c7398114f348e82d809f03c8f11798dfaabf92a2086c63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 36208625 |
| PQID | 2723160075 |
| PQPubID | 23479 |
| PageCount | 19 |
| ParticipantIDs | proquest_miscellaneous_2723160075 pubmed_primary_36208625 crossref_primary_10_1016_j_cmet_2022_09_017 crossref_citationtrail_10_1016_j_cmet_2022_09_017 elsevier_sciencedirect_doi_10_1016_j_cmet_2022_09_017 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-01 2022-11-00 20221101 |
| PublicationDateYYYYMMDD | 2022-11-01 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cell metabolism |
| PublicationTitleAlternate | Cell Metab |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Zhang, Li, Yang, Liu, Lu, Chen, Zhong, Li, Liu, Ou (bib260) 2020; 40 Todoric, Di Caro, Reibe, Henstridge, Green, Vrbanac, Ceteci, Conche, McNulty, Shalapour (bib223) 2020; 2 Verbeke, Farre, Verbinnen, Covens, Vanuytsel, Verhaegen, Komuta, Roskams, Chatterjee, Annaert (bib242) 2015; 185 Albillos, de Gottardi, Rescigno (bib5) 2020; 72 Li, Innocentin, Withers, Roberts, Gallagher, Grigorieva, Wilhelm, Veldhoen (bib132) 2011; 147 Karlsen (bib108) 2016; 65 Guilliams, Bonnardel, Haest, Vanderborght, Wagner, Remmerie, Bujko, Martens, Thoné, Browaeys (bib87) 2022; 185 Kim, Lee, Kim, Seo, Lee, Ha, Lee, Choi, Oh, Yoon (bib112) 2020; 86 Zhu, Gregory, Org, Buffa, Gupta, Wang, Li, Fu, Wu, Mehrabian (bib267) 2016; 165 Voss, Hong, Bader, Sugiura, Lyssiotis, Rathmell (bib244) 2021; 21 Sorribas, Jakob, Yilmaz, Li, Stutz, Noser, de Gottardi, Moghadamrad, Hassan, Albillos (bib210) 2019; 71 Drucker (bib56) 2016; 24 Al-Sadi, Ye, Dokladny, Ma (bib10) 2008; 180 Sellmann, Priebs, Landmann, Degen, Engstler, Jin, Gärttner, Spruss, Huber, Bergheim (bib204) 2015; 26 Temba, Kullaya, Pecht, Mmbaga, Aschenbrenner, Ulas, Kibiki, Lyamuya, Boahen, Kumar (bib217) 2021; 22 Schiattarella, Sannino, Toscano, Giugliano, Gargiulo, Franzone, Trimarco, Esposito, Perrino (bib196) 2017; 38 De Schepper, Verheijden, Aguilera-Lizarraga, Viola, Boesmans, Stakenborg, Voytyuk, Schmidt, Boeckx, Dierckx de Casterle (bib45) 2018; 175 Honda, Surewaard, Watanabe, Hedrick, Lee, Brown, McCoy, Kubes (bib96) 2020; 11 Moriez, Salvador-Cartier, Theodorou, Fioramonti, Eutamene, Bueno (bib156) 2005; 167 Cani, Bibiloni, Knauf, Waget, Neyrinck, Delzenne, Burcelin (bib23) 2008; 57 Chu, Duan, Lang, Jiang, Wang, Llorente, Liu, Mogavero, Bosques-Padilla, Abraldes (bib37) 2020; 72 Steenstraten, Sebib Korkmaz, Trivedi, Inderson, van Hoek, Rodriguez Girondo, Maljaars (bib212) 2019; 49 Karlsen, Sheron, Zelber-Sagi, Carrieri, Dusheiko, Bugianesi, Pryke, Hutchinson, Sangro, Martin (bib110) 2022; 399 de Vos, Tilg, Van Hul, Cani (bib46) 2022; 71 Loomba, Seguritan, Li, Long, Klitgord, Bhatt, Dulai, Caussy, Bettencourt, Highlander (bib140) 2017; 25 Grander, Adolph, Wieser, Lowe, Wrzosek, Gyongyosi, Ward, Grabherr, Gerner, Pfister (bib83) 2018; 67 Harrison, Neff, Guy, Bashir, Paredes, Frias, Younes, Trotter, Gunn, Moussa (bib91) 2021; 160 Perino, Demagny, Velazquez-Villegas, Schoonjans (bib177) 2021; 101 Jiao, Baker, Chapa-Rodriguez, Liu, Nugent, Tsompana, Mastrandrea, Buck, Baker, Genco (bib101) 2018; 67 Ruiz, Casafont, Crespo, Cayón, Mayorga, Estebanez, Fernadez-Escalante, Pons-Romero (bib189) 2007; 17 Verbeke, Farre, Trebicka, Komuta, Roskams, Klein, Elst, Windmolders, Vanuytsel, Nevens (bib241) 2014; 59 Trauner, Fuchs, Halilbasic, Paumgartner (bib226) 2017; 65 Allegretti, Kassam, Carrellas, Mullish, Marchesi, Pechlivanis, Smith, Gerardin, Timberlake, Pratt (bib9) 2019; 114 Pavlidis, Powell, Vincent, Ehrlich, Bjarnason, Hayee (bib174) 2015; 42 Klag, Thomas, Ehmann, Courth, Mailänder-Sanchez, Weiss, Dayoub, Abshagen, Vollmar, Thasler (bib114) 2018; 9 Friedman, Li, Shen, Jiang, Chau, Adorini, Babakhani, Edwards, Shapiro, Zhao (bib69) 2018; 155 Jones, Blagih, Zani, Rees, Hill, Jenkins, Bull, Moreira, Bantan, Cronin (bib104) 2021; 12 Hirschfield, Chazouillères, Drenth, Thorburn, Harrison, Landis, Mayo, Muir, Trotter, Leeming (bib93) 2019; 70 D’Aldebert, Biyeyeme Bi Mve, Mergey, Wendum, Firrincieli, Coilly, Fouassier, Corpechot, Poupon, Housset (bib39) 2009; 136 Salminen, Collado, Endo, Hill, Lebeer, Quigley, Sanders, Shamir, Swann, Szajewska (bib190) 2021; 18 Liwinski, Zenouzi, John, Ehlken, Rühlemann, Bang, Groth, Lieb, Kantowski, Andersen (bib138) 2020; 69 Madara, Stafford (bib144) 1989; 83 Seki, De Minicis, Osterreicher, Kluwe, Osawa, Brenner, Schwabe (bib203) 2007; 13 Martel, Chang, Ko, Hwang, Young, Ojcius (bib146) 2022; 33 Riva, Gray, Azarian, Zamalloa, McPhail, Vincent, Williams, Chokshi, Patel, Edwards (bib188) 2020; 2 Natividad, Augus, Planchais, Lamas, Jarry, Martin, Michel, Chong-Nguyen, Roussel, Straube (bib163) 2018; 28 Loftus, Harewood, Loftus, Tremaine, Harmsen, Zinsmeister, Jewell, Sandborn (bib139) 2005; 54 Hildebrandt, Hoffmann, Sherrill-Mix, Keilbaugh, Hamady, Chen, Knight, Ahima, Bushman, Wu (bib92) 2009; 137 Korem, Zeevi, Zmora, Weissbrod, Bar, Lotan-Pompan, Avnit-Sagi, Kosower, Malka, Rein (bib117) 2017; 25 Libby, Ordovas, Auger, Robbins, Birinyi, Dinarello (bib136) 1986; 124 Zhao, Jang, Liu, Uehara, Gilbert, Izzo, Zeng, Trefely, Fernandez, Carrer (bib263) 2020; 579 Brown, Goldsworthy, Barnes, Eilert, Tcheang, Daniels, Muir, Wigglesworth, Kinghorn, Fraser (bib19) 2003; 278 Chen, Yang, Lu, Wang, Chen, Lei, Wang, Zhu, Li (bib29) 2011; 54 McDonald, Zucoloto, Yu, Burkhard, Brown, Geuking, McCoy (bib150) 2020; 28 Funabashi, Grove, Wang, Varma, McFadden, Brown, Guo, Higginbottom, Almo, Fischbach (bib73) 2020; 582 Segovia-Miranda, Morales-Navarrete, Kücken, Moser, Seifert, Repnik, Rost, Brosch, Hendricks, Hinz (bib202) 2019; 25 Tang, Wang, Levison, Koeth, Britt, Fu, Wu, Hazen (bib215) 2013; 368 Trebicka, Bork, Krag, Arumugam (bib228) 2021; 18 Mouries, Brescia, Silvestri, Spadoni, Sorribas, Wiest, Mileti, Galbiati, Invernizzi, Adorini (bib158) 2019; 71 Caraceni, Vargas, Solà, Alessandria, de Wit, Trebicka, Angeli, Mookerjee, Durand, Pose (bib24) 2021; 74 Schnabl, Brenner (bib199) 2014; 146 Grander, Grabherr, Spadoni, Enrich, Oberhuber, Rescigno, Tilg (bib84) 2020; 12 Frazier, Chang (bib68) 2020; 31 Newsome, Buchholtz, Cusi, Linder, Okanoue, Ratziu, Sanyal, Sejling, Harrison (bib164) 2021; 384 Zhang, Coker, Chu, Fu, Lau, Wang, Chan, Wei, Yang, Sung (bib261) 2021; 70 Anderson, Gayer (bib11) 2021; 10 Schierwagen, Alvarez-Silva, Madsen, Kolbe, Meyer, Thomas, Uschner, Magdaleno, Jansen, Pohlmann (bib197) 2019; 68 Kakiyama, Pandak, Gillevet, Hylemon, Heuman, Daita, Takei, Muto, Nittono, Ridlon (bib107) 2013; 58 Lazarus, Mark, Anstee, Arab, Batterham, Castera, Cortez-Pinto, Crespo, Cusi, Dirac (bib125) 2022; 19 Miele, Valenza, La Torre, Montalto, Cammarota, Ricci, Mascianà, Forgione, Gabrieli, Perotti (bib152) 2009; 49 Delannoy-Bruno, Desai, Raman, Chen, Hibberd, Cheng, Han, Castillo, Couture, Lebrilla (bib47) 2021; 595 Fukui, Brauner, Bode, Bode (bib72) 1991; 12 Abraham, Abreu, Turner (bib1) 2022; 162 Deneau, Mack, Mogul, Perito, Valentino, Amir, DiGuglielmo, Draijer, El-Matary, Furuya (bib49) 2021; 73 Johnson, Heaver, Waters, Kim, Bretin, Goodman, Gewirtz, Worgall, Ley (bib103) 2020; 11 Chiang, Ferrell (bib33) 2022; 548 Quinn, Melnik, Vrbanac, Fu, Patras, Christy, Bodai, Belda-Ferre, Tripathi, Chung (bib183) 2020; 579 Liao, Schneider, Galvez, Frissen, Marschall, Su, Hatting, Wahlström, Haybaeck, Puchas (bib134) 2019; 68 Tyc, Jansen, Schierwagen, Uschner, Israelsen, Klein, Ortiz, Strassburg, Zeuzem, Gu (bib234) 2020; 26 Kummen, Thingholm, Rühlemann, Holm, Hansen, Moitinho-Silva, Liwinski, Zenouzi, Storm-Larsen, Midttun (bib119) 2021; 160 Dantas Machado, Brown, Lingaraju, Sivaganesh, Martino, Chaix, Zhao, Pinto, Chang, Richter (bib41) 2022; 40 Zhao, Zhao, Xiong, He, Huang, Liu, Ji, Pan, Guo, Wang (bib262) 2020; 158 Wrzosek, Ciocan, Hugot, Spatz, Dupeux, on, Lievin-Le Moal, Puchois, Ferrere, Trainel (bib251) 2021; 70 Barberio, Massimi, Cazzagon, Zingone, Ford, Savarino (bib16) 2021; 161 Sookoian, Salatino, Castaño, Landa, Fijalkowky, Garaycoechea, Pirola (bib209) 2020; 69 Inagaki, Moschetta, Lee, Peng, Zhao, Downes, Yu, Shelton, Richardson, Repa (bib99) 2006; 103 Mooradian, Morley, Levine, Prigge, Gebhard (bib155) 1986; 29 Rao, Coyte, Bainter, Geha, Martin, Rakoff-Nahoum (bib185) 2021; 591 Wibowo, Yang, Borry, Hübner, Huang, Tierney, Zimmerman, Barajas-Olmos, Contreras-Cubas, García-Ortiz (bib250) 2021; 594 Clements, Parks, Erwin, Halliday, Barr, Rowlands (bib38) 1996; 39 Tabibian, O'Hara, Trussoni, Tietz, Splinter, Mounajjed, Hagey, LaRusso (bib214) 2016; 63 Radun, Trauner (bib184) 2021; 41 Demir, Lang, Hartmann, Duan, Martin, Miyamoto, Bondareva, Zhang, Wang, Kasper (bib48) 2022; 76 Hoyles, Fernández-Real, Federici, Serino, Abbott, Charpentier, Heymes, Luque, Anthony, Barton (bib98) 2018; 24 Valestrand, Zheng, Hansen, Øgaard, Hov, Björkström, Karlsen, Jiang, Melum (bib238) 2022; 192 Xie, Yagai, Luo, Liang, Chen, Wang, Sun, Zhao, Ramakrishnan, Sun (bib255) 2017; 23 Everard, Belzer, Geurts, Ouwerkerk, Druart, Bindels, Guiot, Derrien, Muccioli, Delzenne (bib61) 2013; 110 Choi, Moschetta, Bookout, Peng, Umetani, Holmstrom, Suino-Powell, Xu, Richardson, Gerard (bib35) 2006; 12 Erridge, Attina, Spickett, Webb (bib60) 2007; 86 Bode, Kugler, Bode (bib18) 1987; 4 Damman, Rodriguez, Ali, Buness, Cox, Carey, Lindor (bib40) 2018; 47 Turner (bib233) 2009; 9 Ghoshal, Witta, Zhong, de Villiers, Eckhardt (bib81) 2009; 50 Lelouvier, Servant, Païssé, Brunet, Benyahya, Serino, Valle, Ortiz, Puig, Courtney (bib128) 2016; 64 Nolan (bib165) 1975; 69 Tremaroli, Karlsson, Werling, Ståhlman, Kovatcheva-Datchary, Olbers, Fändriks, le Roux, Nielsen, Bäckhed (bib230) 2015; 22 Solé, Guilly, Da Silva, Llopis, Le-Chatelier, Huelin, Carol, Moreira, Fabrellas, De Prada (bib207) 2021; 160 Fairfield, Schnabl (bib63) 2021; 3 Dhillon, Kummen, Trøseid, Åkra, Liaskou, Moum, Vesterhus, Karlsen, Seljeflot, Hov (bib53) 2019; 39 Tuganbaev, Mor, Bashiardes, Liwinski, Nobs, Leshem, Dori-Bachash, Thaiss, Pinker, Ratiner (bib231) 2020; 182 Chassaing, Koren, Goodrich, Poole, Srinivasan, Ley, Gewirtz (bib26) 2015; 519 Turnbaugh, Ridaura, Faith, Rey, Knight, Gordon (bib232) 2009; 1 Mueller, Thorell, Claudel, Jha, Koefeler, Lackner, Hoesel, Fauler, Stojakovic, Einarsson (bib160) 2015; 62 Sawey, Chanrion, Cai, Wu, Zhang, Zender, Zhao, Busuttil, Yee, Stein (bib194) 2011; 19 Saran, Dave, Zarrinpar (bib191) 2020; 158 Tilg, Zmora, Adolph, Elinav (bib221) 2020; 20 Devkota, Wang, Musch, Leone, Fehlner-Peach, Nadimpalli, Antonopoulos, Jabri, Chang (bib52) 2012; 487 Zhou, Zhou, Gillilland, Li, Lee, Gao, Zhang, Xu, Owyang (bib266) 2020; 5 Palmela, Peerani, Castaneda, Torres, Itzkowitz (bib170) 2018; 12 Martinez-Guryn, Hubert, Frazier, Urlass, Musch, Ojeda, Pierre, Miyoshi, Sontag, Cham (bib147) 2018; 23 Wu, Chen, Hoffmann, Bittinger, Chen, Keilbaugh, Bewtra, K Chaudhari (10.1016/j.cmet.2022.09.017_bib28) 2021; 29 de Aguiar Vallim (10.1016/j.cmet.2022.09.017_bib43) 2013; 17 Demir (10.1016/j.cmet.2022.09.017_bib48) 2022; 76 Karlsen (10.1016/j.cmet.2022.09.017_bib109) 2017; 67 Zhao (10.1016/j.cmet.2022.09.017_bib263) 2020; 579 Zhou (10.1016/j.cmet.2022.09.017_bib266) 2020; 5 Hofmann (10.1016/j.cmet.2022.09.017_bib94) 2006; 103 Todoric (10.1016/j.cmet.2022.09.017_bib223) 2020; 2 Perino (10.1016/j.cmet.2022.09.017_bib176) 2022; 4 Li (10.1016/j.cmet.2022.09.017_bib133) 2013; 4 Domínguez-Andrés (10.1016/j.cmet.2022.09.017_bib54) 2019; 29 Everard (10.1016/j.cmet.2022.09.017_bib61) 2013; 110 Schiattarella (10.1016/j.cmet.2022.09.017_bib196) 2017; 38 Weismüller (10.1016/j.cmet.2022.09.017_bib249) 2017; 152 Zhou (10.1016/j.cmet.2022.09.017_bib265) 2014; 74 Jones (10.1016/j.cmet.2022.09.017_bib104) 2021; 12 Ridlon (10.1016/j.cmet.2022.09.017_bib187) 2006; 47 Tuganbaev (10.1016/j.cmet.2022.09.017_bib231) 2020; 182 Miele (10.1016/j.cmet.2022.09.017_bib152) 2009; 49 Formes (10.1016/j.cmet.2022.09.017_bib67) 2021; 24 Lee (10.1016/j.cmet.2022.09.017_bib126) 2022; 377 Schaap (10.1016/j.cmet.2022.09.017_bib195) 2009; 49 Moriez (10.1016/j.cmet.2022.09.017_bib156) 2005; 167 Trebicka (10.1016/j.cmet.2022.09.017_bib228) 2021; 18 Koh (10.1016/j.cmet.2022.09.017_bib116) 2018; 175 Saran (10.1016/j.cmet.2022.09.017_bib191) 2020; 158 Temba (10.1016/j.cmet.2022.09.017_bib217) 2021; 22 Alferink (10.1016/j.cmet.2022.09.017_bib7) 2021; 73 Schierwagen (10.1016/j.cmet.2022.09.017_bib197) 2019; 68 De Filippo (10.1016/j.cmet.2022.09.017_bib44) 2010; 107 Choi (10.1016/j.cmet.2022.09.017_bib36) 2021; 18 Schwabl (10.1016/j.cmet.2022.09.017_bib201) 2017; 66 Cani (10.1016/j.cmet.2022.09.017_bib23) 2008; 57 Alemán (10.1016/j.cmet.2022.09.017_bib6) 2021; 5 Lajczak (10.1016/j.cmet.2022.09.017_bib121) 2017; 31 Perino (10.1016/j.cmet.2022.09.017_bib177) 2021; 101 Barberio (10.1016/j.cmet.2022.09.017_bib16) 2021; 161 Gege (10.1016/j.cmet.2022.09.017_bib79) 2019; 256 Jin (10.1016/j.cmet.2022.09.017_bib102) 2022; 36 Smith (10.1016/j.cmet.2022.09.017_bib206) 2013; 341 Kremoser (10.1016/j.cmet.2022.09.017_bib118) 2021; 75 Mueller (10.1016/j.cmet.2022.09.017_bib160) 2015; 62 Asrani (10.1016/j.cmet.2022.09.017_bib13) 2019; 70 Dantas Machado (10.1016/j.cmet.2022.09.017_bib41) 2022; 40 Voss (10.1016/j.cmet.2022.09.017_bib244) 2021; 21 Xie (10.1016/j.cmet.2022.09.017_bib254) 2017; 66 Chiang (10.1016/j.cmet.2022.09.017_bib33) 2022; 548 Montrose (10.1016/j.cmet.2022.09.017_bib154) 2021; 11 Juneja (10.1016/j.cmet.2022.09.017_bib106) 2022; 322 Tilg (10.1016/j.cmet.2022.09.017_bib220) 2011; 55 Zhu (10.1016/j.cmet.2022.09.017_bib267) 2016; 165 Cani (10.1016/j.cmet.2022.09.017_bib21) 2021; 33 Van Olden (10.1016/j.cmet.2022.09.017_bib240) 2021; 289 Alisi (10.1016/j.cmet.2022.09.017_bib8) 2010; 50 van Dijk (10.1016/j.cmet.2022.09.017_bib239) 2009; 90 Bailey (10.1016/j.cmet.2022.09.017_bib14) 1976; 63 Tilg (10.1016/j.cmet.2022.09.017_bib268) 2022; 34 Leshem (10.1016/j.cmet.2022.09.017_bib131) 2020; 78 Uesugi (10.1016/j.cmet.2022.09.017_bib236) 2001; 34 Makki (10.1016/j.cmet.2022.09.017_bib145) 2018; 23 Loftus (10.1016/j.cmet.2022.09.017_bib139) 2005; 54 Clements (10.1016/j.cmet.2022.09.017_bib38) 1996; 39 Agus (10.1016/j.cmet.2022.09.017_bib4) 2021; 70 Palmela (10.1016/j.cmet.2022.09.017_bib170) 2018; 12 Tomlinson (10.1016/j.cmet.2022.09.017_bib224) 2002; 143 Shah (10.1016/j.cmet.2022.09.017_bib205) 2019; 39 Laval (10.1016/j.cmet.2022.09.017_bib124) 2015; 6 Ghosh (10.1016/j.cmet.2022.09.017_bib80) 2013; 110 Johnson (10.1016/j.cmet.2022.09.017_bib103) 2020; 11 Sawey (10.1016/j.cmet.2022.09.017_bib194) 2011; 19 Abraham (10.1016/j.cmet.2022.09.017_bib1) 2022; 162 Fuchs (10.1016/j.cmet.2022.09.017_bib71) 2022; 19 Klag (10.1016/j.cmet.2022.09.017_bib114) 2018; 9 Nordenvall (10.1016/j.cmet.2022.09.017_bib166) 2018; 47 Mayo (10.1016/j.cmet.2022.09.017_bib148) 2018; 2 Fabbiano (10.1016/j.cmet.2022.09.017_bib62) 2018; 28 Wibowo (10.1016/j.cmet.2022.09.017_bib250) 2021; 594 Yoon (10.1016/j.cmet.2022.09.017_bib258) 2021; 6 Li (10.1016/j.cmet.2022.09.017_bib132) 2011; 147 Hoyles (10.1016/j.cmet.2022.09.017_bib98) 2018; 24 Kummen (10.1016/j.cmet.2022.09.017_bib119) 2021; 160 Karlsen (10.1016/j.cmet.2022.09.017_bib110) 2022; 399 Xie (10.1016/j.cmet.2022.09.017_bib255) 2017; 23 Wang (10.1016/j.cmet.2022.09.017_bib248) 2020; 2020 Muñoz (10.1016/j.cmet.2022.09.017_bib161) 2019; 70 Han (10.1016/j.cmet.2022.09.017_bib88) 2021; 373 Pendyala (10.1016/j.cmet.2022.09.017_bib175) 2012; 142 Madara (10.1016/j.cmet.2022.09.017_bib144) 1989; 83 Solé (10.1016/j.cmet.2022.09.017_bib207) 2021; 160 Choi (10.1016/j.cmet.2022.09.017_bib35) 2006; 12 Radun (10.1016/j.cmet.2022.09.017_bib184) 2021; 41 Trebicka (10.1016/j.cmet.2022.09.017_bib229) 2021; 75 Gadishaw-Lue (10.1016/j.cmet.2022.09.017_bib75) 2021; 89 Chen (10.1016/j.cmet.2022.09.017_bib30) 2015; 61 Martinez-Guryn (10.1016/j.cmet.2022.09.017_bib147) 2018; 23 Sookoian (10.1016/j.cmet.2022.09.017_bib209) 2020; 69 Bode (10.1016/j.cmet.2022.09.017_bib18) 1987; 4 McBrearty (10.1016/j.cmet.2022.09.017_bib149) 2021; 23 Patel Chavez (10.1016/j.cmet.2022.09.017_bib172) 2022; 107 Fang (10.1016/j.cmet.2022.09.017_bib64) 2015; 21 Anderson (10.1016/j.cmet.2022.09.017_bib11) 2021; 10 Martel (10.1016/j.cmet.2022.09.017_bib146) 2022; 33 Seki (10.1016/j.cmet.2022.09.017_bib203) 2007; 13 Spadoni (10.1016/j.cmet.2022.09.017_bib211) 2015; 350 Chu (10.1016/j.cmet.2022.09.017_bib37) 2020; 72 Verbeke (10.1016/j.cmet.2022.09.017_bib242) 2015; 185 Chiang (10.1016/j.cmet.2022.09.017_bib32) 2009; 50 Fukui (10.1016/j.cmet.2022.09.017_bib72) 1991; 12 Liwinski (10.1016/j.cmet.2022.09.017_bib138) 2020; 69 Remetic (10.1016/j.cmet.2022.09.017_bib186) 2022; 75 Campbell (10.1016/j.cmet.2022.09.017_bib20) 2020; 581 Quinn (10.1016/j.cmet.2022.09.017_bib183) 2020; 579 Wahlström (10.1016/j.cmet.2022.09.017_bib246) 2016; 24 Yan (10.1016/j.cmet.2022.09.017_bib256) 2021; 5 Tranah (10.1016/j.cmet.2022.09.017_bib225) 2021; 70 Hov (10.1016/j.cmet.2022.09.017_bib97) 2017; 37 Leonardi (10.1016/j.cmet.2022.09.017_bib129) 2022; 185 Dong (10.1016/j.cmet.2022.09.017_bib55) 2020; 12 Miyata (10.1016/j.cmet.2022.09.017_bib153) 2012; 132 Engelmann (10.1016/j.cmet.2022.09.017_bib59) 2020; 73 Frazier (10.1016/j.cmet.2022.09.017_bib68) 2020; 31 Drucker (10.1016/j.cmet.2022.09.017_bib56) 2016; 24 Fairfield (10.1016/j.cmet.2022.09.017_bib63) 2021; 3 Trauner (10.1016/j.cmet.2022.09.017_bib226) 2017; 65 Vujkovic-Cvijin (10.1016/j.cmet.2022.09.017_bib245) 2020; 587 Granowitz (10.1016/j.cmet.2022.09.017_bib85) 1991; 338 Sun (10.1016/j.cmet.2022.09.017_bib213) 2018; 24 Grander (10.1016/j.cmet.2022.09.017_bib84) 2020; 12 Jordan (10.1016/j.cmet.2022.09.017_bib105) 2019; 178 Karpen (10.1016/j.cmet.2022.09.017_bib111) 2020; 14 D’Aldebert (10.1016/j.cmet.2022.09.017_bib39) 2009; 136 Muegge (10.1016/j.cmet.2022.09.017_bib159) 2011; 332 Song (10.1016/j.cmet.2022.09.017_bib208) 2020; 577 Qin (10.1016/j.cmet.2022.09.017_bib182) 2014; 513 Wu (10.1016/j.cmet.2022.09.017_bib252) 2011; 334 Deng (10.1016/j.cmet.2022.09.017_bib50) 2020; 245 Metzendorf (10.1016/j.cmet.2022.09.017_bib151) 2022; 13 Nakamoto (10.1016/j.cmet.2022.09.017_bib162) 2019; 4 Acharya (10.1016/j.cmet.2022.09.017_bib2) 2021; 160 Tyc (10.1016/j.cmet.2022.09.017_bib234) 2020; 26 Hofmann (10.1016/j.cmet.2022.09.017_bib95) 2014; 55 Kim (10.1016/j.cmet.2022.09.017_bib112) 2020; 86 Poltorak (10.1016/j.cmet.2022.09.017_bib179) 1998; 282 Korem (10.1016/j.cmet.2022.09.017_bib117) 2017; 25 Parlesak (10.1016/j.cmet.2022.09.017_bib171) 2000; 32 Kiss (10.1016/j.cmet.2022.09.017_bib113) 2011; 334 Andersen (10.1016/j.cmet.2022.09.017_bib12) 2018; 14 de Vos (10.1016/j.cmet.2022.09.017_bib46) 2022; 71 Tabibian (10.1016/j.cmet.2022.09.017_bib214) 2016; 63 Qian (10.1016/j.cmet.2022.09.017_bib181) 2022; 13 Loomba (10.1016/j.cmet.2022.09.017_bib140) 2017; 25 Allegretti (10.1016/j.cmet.2022.09.017_bib9) 2019; 114 Grander (10.1016/j.cmet.2022.09.017_bib83) 2018; 67 Delannoy-Bruno (10.1016/j.cmet.2022.09.017_bib47) 2021; 595 Zhao (10.1016/j.cmet.2022.09.017_bib262) 2020; 158 Lelouvier (10.1016/j.cmet.2022.09.017_bib128) 2016; 64 Valestrand (10.1016/j.cmet.2022.09.017_bib238) 2022; 192 Nolan (10.1016/j.cmet.2022.09.017_bib165) 1975; 69 Brown (10.1016/j.cmet.2022.09.017_bib19) 2003; 278 Erridge (10.1016/j.cmet.2022.09.017_bib60) 2007; 86 Hang (10.1016/j.cmet.2022.09.017_bib89) 2019; 576 Chassaing (10.1016/j.cmet.2022.09.017_bib26) 2015; 519 Hirschfield (10.1016/j.cmet.2022.09.017_bib93) 2019; 70 Harrison (10.1016/j.cmet.2022.09.017_bib90) 2020; 71 Hildebrandt (10.1016/j.cmet.2022.09.017_bib92) 2009; 137 Liaskou (10.1016/j.cmet.2022.09.017_bib135) 2022; 38 Lazarus (10.1016/j.cmet.2022.09.017_bib125) 2022; 19 Tang (10.1016/j.cmet.2022.09.017_bib215) 2013; 368 Newsome (10.1016/j.cmet.2022.09.017_bib164) 2021; 384 Ghoshal (10.1016/j.cmet.2022.09.017_bib81) 2009; 50 Jiao (10.1016/j.cmet.2022.09.017_bib101) 2018; 67 Grosheva (10.1016/j.cmet.2022.09.017_bib86) 2020; 159 Zheng (10.1016/j.cmet.2022.09.017_bib264) 2021; 33 Albillos (10.1016/j.cmet.2022.09.017_bib5) 2020; 72 Funabashi (10.1016/j.cmet.2022.09.017_bib73) 2020; 582 Teratani (10.1016/j.cmet.2022.09.017_bib218) 2020; 585 Lang (10.1016/j.cmet.2022.09.017_bib122) 2020; 71 Guilliams (10.1016/j.cmet.2022.09.017_bib87) 2022; 185 Zeng (10.1016/j.cmet.2022.09.017_bib259) 2015; 16 Chen (10.1016/j.cmet.2022.09.017_bib31) 2016; 6 Luther (10.1016/j.cmet.2022.09.017_bib143) 2015; 1 Oh (10.1016/j.cmet.2022.09.017_bib167) 2020; 32 Harrison (10.1016/j.cmet.2022.09.017_bib91) 2021; 160 Turnbaugh (10.1016/j.cmet.2022.09.017_bib232) 2009; 1 Turner (10.1016/j.cmet.2022.09.017_bib233) 2009; 9 Fon Tacer (10.1016/j.cmet.2022.09.017_bib66) 2010; 24 Gao (10.1016/j.cmet.2022.09.017_bib76) 2014; 118 Liu (10.1016/j.cmet.2022.09.017_bib137) 2020; 71 Uriarte (10.1016/j.cmet.2022.09.017_bib237) 2013; 62 León-Mimila (10.1016/j.cmet.2022.09.017_bib130) 2021; 47 Lassailly (10.1016/j.cmet.2022.09.017_bib123) 2020; 159 Pathak (10.1016/j.cmet.2022.09.017_bib173) 2018; 68 Riva (10.1016/j.cmet.2022.09.017_bib188) 2020; 2 Damman (10.1016/j.cmet.2022.09.017_bib40) 2018; 47 Ruiz (10.1016/j.cmet.2022.09.017_bib189) 2007; |
| References_xml | – volume: 31 start-page: 3848 year: 2017 end-page: 3857 ident: bib121 article-title: Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human beta-defensin-1 and -2 secretion by colonic epithelial cells publication-title: FASEB J. – volume: 14 start-page: 390 year: 2018 end-page: 403 ident: bib12 article-title: Glucagon-like peptide 1 in health and disease publication-title: Nat. Rev. Endocrinol. – volume: 73 start-page: 102 year: 2020 end-page: 112 ident: bib59 article-title: Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure publication-title: J. Hepatol. – volume: 70 start-page: 483 year: 2019 end-page: 493 ident: bib93 article-title: Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial publication-title: J. Hepatol. – volume: 29 start-page: 221 year: 1986 end-page: 224 ident: bib155 article-title: Abnormal intestinal permeability to sugars in diabetes mellitus publication-title: Diabetologia – volume: 49 start-page: 636 year: 2019 end-page: 643 ident: bib212 article-title: Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation publication-title: Aliment. Pharmacol. Ther. – volume: 83 start-page: 724 year: 1989 end-page: 727 ident: bib144 article-title: Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers publication-title: J. Clin. Invest. – volume: 118 start-page: 476 year: 2014 end-page: 481 ident: bib76 article-title: Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet publication-title: J. Biosci. Bioeng. – volume: 10 start-page: 3206 year: 2021 ident: bib11 article-title: The pathophysiology of farnesoid X receptor (FXR) in the GI tract: inflammation, barrier function and innate immunity publication-title: Cells – volume: 49 start-page: 1877 year: 2009 end-page: 1887 ident: bib152 article-title: Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 54 start-page: 91 year: 2005 end-page: 96 ident: bib139 article-title: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis publication-title: Gut – volume: 146 start-page: 1513 year: 2014 end-page: 1524 ident: bib199 article-title: Interactions between the intestinal microbiome and liver diseases publication-title: Gastroenterology – volume: 368 start-page: 1575 year: 2013 end-page: 1584 ident: bib215 article-title: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk publication-title: N. Engl. J. Med. – volume: 9 start-page: 799 year: 2009 end-page: 809 ident: bib233 article-title: Intestinal mucosal barrier function in health and disease publication-title: Nat. Rev. Immunol. – volume: 14 start-page: 2029674 year: 2022 ident: bib78 article-title: Circulating microbiome in patients with portal hypertension publication-title: Gut Microbes – volume: 70 start-page: 522 year: 2021 end-page: 530 ident: bib70 article-title: Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function publication-title: Gut – volume: 69 start-page: 1346 year: 1975 end-page: 1356 ident: bib165 article-title: The role of endotoxin in liver injury publication-title: Gastroenterology – volume: 62 start-page: 899 year: 2013 end-page: 910 ident: bib237 article-title: Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice publication-title: Gut – volume: 39 start-page: 432 year: 2019 end-page: 441 ident: bib205 article-title: Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis publication-title: Semin. Liver Dis. – volume: 12 start-page: 1859812 year: 2020 ident: bib55 article-title: The aryl hydrocarbon receptor as a mediator of host-microbiota interplay publication-title: Gut Microbes – volume: 23 start-page: 458 year: 2018 end-page: 469.e5 ident: bib147 article-title: Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids publication-title: Cell Host Microbe – volume: 13 start-page: 729 year: 2011 end-page: 738 ident: bib180 article-title: FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway publication-title: Cell Metab. – volume: 73 start-page: 968 year: 2021 end-page: 982 ident: bib7 article-title: Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults publication-title: Hepatology – volume: 162 start-page: 743 year: 2022 end-page: 756 ident: bib27 article-title: Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome publication-title: Gastroenterology – volume: 377 start-page: eabp9960 year: 2022 ident: bib126 article-title: The microbiome and gut homeostasis publication-title: Science – volume: 5 start-page: e138881 year: 2020 ident: bib266 article-title: Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding publication-title: JCI Insight – volume: 13 start-page: 233 year: 2022 end-page: 256 ident: bib181 article-title: Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease publication-title: Cell. Mol. Gastroenterol. Hepatol. – volume: 36 start-page: e22174 year: 2022 ident: bib102 article-title: Colonic interleukin-22 protects intestinal mucosal barrier and microbiota abundance in severe acute pancreatitis publication-title: FASEB J. – volume: 38 start-page: 2948 year: 2017 end-page: 2956 ident: bib196 article-title: Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis publication-title: Eur. Heart J. – volume: 24 start-page: 41 year: 2016 end-page: 50 ident: bib246 article-title: Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism publication-title: Cell Metab. – volume: 472 start-page: 57 year: 2011 end-page: 63 ident: bib247 article-title: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease publication-title: Nature – volume: 71 start-page: 2050 year: 2020 end-page: 2066 ident: bib137 article-title: Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice publication-title: Hepatology – volume: 69 start-page: 665 year: 2020 end-page: 672 ident: bib138 article-title: Alterations of the bile microbiome in primary sclerosing cholangitis publication-title: Gut – volume: 70 start-page: 1299 year: 2021 end-page: 1308 ident: bib251 article-title: Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury publication-title: Gut – volume: 11 start-page: 2471 year: 2020 ident: bib103 article-title: Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels publication-title: Nat. Commun. – volume: 12 start-page: 7172 year: 2021 ident: bib58 article-title: CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease publication-title: Nat. Commun. – volume: 384 start-page: 1113 year: 2021 end-page: 1124 ident: bib164 article-title: A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis publication-title: N. Engl. J. Med. – volume: 33 start-page: 2316 year: 2021 end-page: 2328 ident: bib65 article-title: "Sweet death": fructose as a metabolic toxin that targets the gut-liver axis publication-title: Cell Metab. – volume: 350 start-page: 830 year: 2015 end-page: 834 ident: bib211 article-title: A gut-vascular barrier controls the systemic dissemination of bacteria publication-title: Science – volume: 11 start-page: 1329 year: 2020 ident: bib96 article-title: Perivascular localization of macrophages in the intestinal mucosa is regulated by Nr4a1 and the microbiome publication-title: Nat. Commun. – volume: 161 start-page: 1865 year: 2021 end-page: 1877 ident: bib16 article-title: Prevalence of primary sclerosing cholangitis in patients With inflammatory bowel disease: a systematic review and meta-analysis publication-title: Gastroenterology – volume: 22 start-page: 228 year: 2015 end-page: 238 ident: bib230 article-title: Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation publication-title: Cell Metab. – volume: 70 start-page: 925 year: 2019 end-page: 938 ident: bib161 article-title: Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis publication-title: Hepatology – volume: 38 start-page: 104 year: 2022 end-page: 113 ident: bib135 article-title: Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again publication-title: Curr. Opin. Gastroenterol. – volume: 24 start-page: 15 year: 2016 end-page: 30 ident: bib56 article-title: The cardiovascular biology of glucagon-like peptide-1 publication-title: Cell Metab. – volume: 22 start-page: 266 year: 2015 end-page: 278 ident: bib253 article-title: Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis publication-title: Cell Metab. – volume: 67 start-page: 891 year: 2018 end-page: 901 ident: bib83 article-title: Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease publication-title: Gut – volume: 6 start-page: 19076 year: 2016 ident: bib31 article-title: Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults publication-title: Sci. Rep. – volume: 76 start-page: 788 year: 2022 end-page: 799 ident: bib48 article-title: The fecal mycobiome in non-alcoholic fatty liver disease publication-title: J. Hepatol. – volume: 18 start-page: 167 year: 2021 end-page: 180 ident: bib228 article-title: Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 86 start-page: 1286 year: 2007 end-page: 1292 ident: bib60 article-title: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation publication-title: Am. J. Clin. Nutr. – volume: 399 start-page: 61 year: 2022 end-page: 116 ident: bib110 article-title: The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality publication-title: Lancet – volume: 2020 start-page: 6672636 year: 2020 ident: bib248 article-title: High-fructose diet increases inflammatory cytokines and alters gut microbiota composition in rats publication-title: Mediators Inflamm. – volume: 23 start-page: 1298 year: 2017 end-page: 1308 ident: bib255 article-title: Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis publication-title: Nat. Med. – volume: 2 start-page: 100151 year: 2020 ident: bib188 article-title: Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis publication-title: JHEP Rep. – volume: 19 start-page: 60 year: 2022 end-page: 78 ident: bib125 article-title: Advancing the global public health agenda for NAFLD: a consensus statement publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 74 start-page: 3306 year: 2014 end-page: 3316 ident: bib265 article-title: Separating tumorigenicity from bile acid regulatory activity for endocrine hormone FGF19 publication-title: Cancer Res. – volume: 57 start-page: 1470 year: 2008 end-page: 1481 ident: bib23 article-title: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice publication-title: Diabetes – volume: 12 start-page: 41 year: 2022 ident: bib77 article-title: Machine learning applied to omics datasets predicts mortality in patients with alcoholic hepatitis publication-title: Metabolites – volume: 20 start-page: 40 year: 2020 end-page: 54 ident: bib221 article-title: The intestinal microbiota fuelling metabolic inflammation publication-title: Nat. Rev. Immunol. – volume: 18 start-page: 679 year: 2021 end-page: 689 ident: bib36 article-title: Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 175 start-page: 947 year: 2018 end-page: 961.e17 ident: bib116 article-title: Microbially produced imidazole propionate impairs insulin signaling through mTORC1 publication-title: Cell – volume: 25 start-page: 1243 year: 2017 end-page: 1253.e5 ident: bib117 article-title: Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses publication-title: Cell Metab. – volume: 25 start-page: 1096 year: 2019 end-page: 1103 ident: bib51 article-title: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study publication-title: Nat. Med. – volume: 334 start-page: 105 year: 2011 end-page: 108 ident: bib252 article-title: Linking long-term dietary patterns with gut microbial enterotypes publication-title: Science – volume: 103 start-page: 3920 year: 2006 end-page: 3925 ident: bib99 article-title: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor publication-title: Proc. Natl. Acad. Sci. USA – volume: 25 start-page: 1885 year: 2019 end-page: 1893 ident: bib202 article-title: Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression publication-title: Nat. Med. – volume: 158 start-page: 2266 year: 2020 end-page: 2281.e27 ident: bib262 article-title: TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits gamma-butyrobetaine hydroxylase, and exacerbates fatty liver in mice publication-title: Gastroenterology – volume: 112 start-page: 137 year: 1999 end-page: 146 ident: bib198 article-title: Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6 publication-title: J. Cell Sci. – volume: 86 year: 2020 ident: bib112 article-title: Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis publication-title: Appl. Environ. Microbiol. – volume: 505 start-page: 559 year: 2014 end-page: 563 ident: bib42 article-title: Diet rapidly and reproducibly alters the human gut microbiome publication-title: Nature – volume: 595 start-page: 91 year: 2021 end-page: 95 ident: bib47 article-title: Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans publication-title: Nature – volume: 5 start-page: e143 year: 2021 ident: bib6 article-title: Excess dietary fructose does not alter gut microbiota or permeability in humans: a pilot randomized controlled study publication-title: J. Clin. Transl. Sci. – volume: 159 start-page: 1807 year: 2020 end-page: 1823 ident: bib86 article-title: High-throughput screen identifies host and microbiota regulators of intestinal barrier function publication-title: Gastroenterology – volume: 23 start-page: 705 year: 2018 end-page: 715 ident: bib145 article-title: The impact of dietary fiber on gut microbiota in host health and disease publication-title: Cell Host Microbe – volume: 1 start-page: 6ra14 year: 2009 ident: bib232 article-title: The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice publication-title: Sci. Transl. Med. – volume: 11 start-page: 525 year: 2021 end-page: 550 ident: bib154 article-title: Dietary fructose alters the composition, localization, and metabolism of gut microbiota in association with worsening colitis publication-title: Cell. Mol. Gastroenterol. Hepatol. – volume: 142 start-page: 1100 year: 2012 end-page: 1101.e2 ident: bib175 article-title: A high-fat diet is associated with endotoxemia that originates from the gut publication-title: Gastroenterology – volume: 160 start-page: 1784 year: 2021 end-page: 1798.e0 ident: bib119 article-title: Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis publication-title: Gastroenterology – volume: 73 start-page: 1061 year: 2021 end-page: 1073 ident: bib49 article-title: Oral vancomycin, ursodeoxycholic acid, or no therapy for pediatric primary sclerosing cholangitis: a matched analysis publication-title: Hepatology – volume: 143 start-page: 1741 year: 2002 end-page: 1747 ident: bib224 article-title: Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity publication-title: Endocrinology – volume: 595 start-page: 272 year: 2021 end-page: 277 ident: bib243 article-title: Caloric restriction disrupts the microbiota and colonization resistance publication-title: Nature – volume: 103 start-page: 4333 year: 2006 end-page: 4334 ident: bib94 article-title: How bile acids confer gut mucosal protection against bacteria publication-title: Proc. Natl. Acad. Sci. USA – volume: 28 start-page: 907 year: 2018 end-page: 921.e7 ident: bib62 article-title: Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements publication-title: Cell Metab. – volume: 40 start-page: 751 year: 2020 end-page: 765 ident: bib260 article-title: Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-kappaB (nuclear factor kappa B) signals publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 178 start-page: 1102 year: 2019 end-page: 1114.e17 ident: bib105 article-title: Dietary intake regulates the circulating inflammatory monocyte pool publication-title: Cell – volume: 14 start-page: 279 year: 2017 end-page: 295 ident: bib100 article-title: Genetics of primary sclerosing cholangitis and pathophysiological implications publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 75 start-page: 1095 year: 2022 end-page: 1109 ident: bib186 article-title: Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance publication-title: Hepatology – volume: 182 start-page: 1441 year: 2020 end-page: 1459.e21 ident: bib231 article-title: Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis publication-title: Cell – volume: 359 start-page: 1376 year: 2018 end-page: 1383 ident: bib219 article-title: Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection publication-title: Science – volume: 341 start-page: 569 year: 2013 end-page: 573 ident: bib206 article-title: The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis publication-title: Science – volume: 1 start-page: 222 year: 2015 end-page: 232 ident: bib143 article-title: Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability publication-title: Cell. Mol. Gastroenterol. Hepatol. – volume: 63 start-page: 185 year: 2016 end-page: 196 ident: bib214 article-title: Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis publication-title: Hepatology – volume: 68 start-page: 234 year: 2018 end-page: 247 ident: bib15 article-title: Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort publication-title: Hepatology – volume: 4 start-page: 2384 year: 2013 ident: bib133 article-title: Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity publication-title: Nat. Commun. – volume: 575 start-page: 505 year: 2019 end-page: 511 ident: bib57 article-title: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease publication-title: Nature – volume: 160 start-page: 219 year: 2021 end-page: 231.e1 ident: bib91 article-title: Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis publication-title: Gastroenterology – volume: 62 start-page: 1398 year: 2015 end-page: 1404 ident: bib160 article-title: Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity publication-title: J. Hepatol. – volume: 579 start-page: 123 year: 2020 end-page: 129 ident: bib183 article-title: Global chemical effects of the microbiome include new bile-acid conjugations publication-title: Nature – volume: 50 start-page: 90 year: 2009 end-page: 97 ident: bib81 article-title: Chylomicrons promote intestinal absorption of lipopolysaccharides publication-title: J. Lipid Res. – volume: 110 start-page: 515 year: 2013 end-page: 523 ident: bib80 article-title: Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice publication-title: Br. J. Nutr. – volume: 278 start-page: 11312 year: 2003 end-page: 11319 ident: bib19 article-title: The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids publication-title: J. Biol. Chem. – volume: 579 start-page: 586 year: 2020 end-page: 591 ident: bib263 article-title: Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate publication-title: Nature – volume: 71 start-page: 1126 year: 2019 end-page: 1140 ident: bib210 article-title: FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis publication-title: J. Hepatol. – volume: 23 start-page: 529 year: 2021 end-page: 538 ident: bib149 article-title: Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice publication-title: Neoplasia – volume: 32 start-page: 878 year: 2020 end-page: 888.e6 ident: bib167 article-title: A universal gut-microbiome-derived signature predicts cirrhosis publication-title: Cell Metab. – volume: 3 start-page: 1596 year: 2021 end-page: 1607 ident: bib222 article-title: Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity publication-title: Nat. Metab. – volume: 29 start-page: 211 year: 2019 end-page: 220.e5 ident: bib54 article-title: The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity publication-title: Cell Metab. – volume: 64 start-page: 1049 year: 2016 end-page: 1057 ident: bib235 article-title: Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats publication-title: J. Hepatol. – volume: 591 start-page: 633 year: 2021 end-page: 638 ident: bib185 article-title: Multi-kingdom ecological drivers of microbiota assembly in preterm infants publication-title: Nature – volume: 68 start-page: 1574 year: 2018 end-page: 1588 ident: bib173 article-title: Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism publication-title: Hepatology – volume: 37 start-page: 314 year: 2017 end-page: 331 ident: bib97 article-title: The microbiome in primary sclerosing cholangitis: current evidence and potential concepts publication-title: Semin. Liver Dis. – volume: 47 start-page: 241 year: 2006 end-page: 259 ident: bib187 article-title: Bile salt biotransformations by human intestinal bacteria publication-title: J. Lipid Res. – volume: 19 start-page: 432 year: 2022 end-page: 450 ident: bib71 article-title: Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 373 start-page: eabe6729 year: 2021 ident: bib88 article-title: Enterically derived high-density lipoprotein restrains liver injury through the portal vein publication-title: Science – volume: 65 start-page: 1393 year: 2017 end-page: 1404 ident: bib226 article-title: New therapeutic concepts in bile acid transport and signaling for management of cholestasis publication-title: Hepatology – volume: 55 start-page: 1159 year: 2011 end-page: 1161 ident: bib220 article-title: Pathways of liver injury in alcoholic liver disease publication-title: J. Hepatol. – volume: 160 start-page: 556 year: 2021 end-page: 572 ident: bib2 article-title: Chronic liver diseases and the microbiome-translating our knowledge of gut microbiota to management of chronic liver disease publication-title: Gastroenterology – volume: 175 start-page: 400 year: 2018 end-page: 415.e3 ident: bib45 article-title: Self-maintaining gut macrophages are essential for intestinal homeostasis publication-title: Cell – volume: 70 start-page: 1174 year: 2021 end-page: 1182 ident: bib4 article-title: Gut microbiota-derived metabolites as central regulators in metabolic disorders publication-title: Gut – volume: 185 start-page: 379 year: 2022 end-page: 396.e38 ident: bib87 article-title: Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches publication-title: Cell – volume: 12 start-page: 162 year: 1991 end-page: 169 ident: bib72 article-title: Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay publication-title: J. Hepatol. – volume: 89 year: 2021 ident: bib75 article-title: Bile salts differentially enhance resistance of enterohemorrhagic Escherichia coli O157:H7 to host defense peptides publication-title: Infect. Immun. – volume: 21 start-page: 527 year: 2015 end-page: 542 ident: bib142 article-title: Regulation of obesity-related insulin resistance with gut anti-inflammatory agents publication-title: Cell Metab. – volume: 72 start-page: 391 year: 2020 end-page: 400 ident: bib37 article-title: The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease publication-title: J. Hepatol. – volume: 68 start-page: 578 year: 2019 end-page: 580 ident: bib197 article-title: Circulating microbiome in blood of different circulatory compartments publication-title: Gut – volume: 13 start-page: 814692 year: 2022 ident: bib151 article-title: Destination and specific impact of different bile acids in the intestinal pathogen Clostridioides difficile publication-title: Front. Microbiol. – volume: 59 start-page: 2286 year: 2014 end-page: 2298 ident: bib241 article-title: Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats publication-title: Hepatology – volume: 72 start-page: 558 year: 2020 end-page: 577 ident: bib5 article-title: The gut-liver axis in liver disease: pathophysiological basis for therapy publication-title: J. Hepatol. – volume: 41 start-page: 461 year: 2021 end-page: 475 ident: bib184 article-title: Role of FXR in bile acid and metabolic homeostasis in NASH: pathogenetic concepts and therapeutic opportunities publication-title: Semin. Liver Dis. – volume: 581 start-page: 475 year: 2020 end-page: 479 ident: bib20 article-title: Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells publication-title: Nature – volume: 3 start-page: 100220 year: 2021 ident: bib63 article-title: Gut dysbiosis as a driver in alcohol-induced liver injury publication-title: JHEP Rep. – volume: 70 start-page: 982 year: 2021 end-page: 994 ident: bib225 article-title: Targeting the gut-liver-immune axis to treat cirrhosis publication-title: Gut – volume: 24 start-page: 1070 year: 2018 end-page: 1080 ident: bib98 article-title: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women publication-title: Nat. Med. – volume: 37 start-page: 551 year: 2003 end-page: 557 ident: bib141 article-title: Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats publication-title: Hepatology – volume: 54 start-page: 562 year: 2011 end-page: 572 ident: bib29 article-title: Characterization of fecal microbial communities in patients with liver cirrhosis publication-title: Hepatology – volume: 159 start-page: 1290 year: 2020 end-page: 1301.e5 ident: bib123 article-title: Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis publication-title: Gastroenterology – volume: 289 start-page: 340 year: 2021 end-page: 354 ident: bib240 article-title: A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study publication-title: J. Intern. Med. – volume: 65 start-page: 1579 year: 2016 end-page: 1581 ident: bib108 article-title: Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love? publication-title: Gut – volume: 24 start-page: 1919 year: 2018 end-page: 1929 ident: bib213 article-title: Gut microbiota and intestinal FXR mediate the clinical benefits of metformin publication-title: Nat. Med. – volume: 32 start-page: 742 year: 2000 end-page: 747 ident: bib171 article-title: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease publication-title: J. Hepatol. – volume: 67 start-page: 1881 year: 2018 end-page: 1891 ident: bib101 article-title: Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD publication-title: Gut – volume: 50 start-page: 645 year: 2010 end-page: 649 ident: bib8 article-title: Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children publication-title: J. Pediatr. Gastroenterol. Nutr. – volume: 31 start-page: 25 year: 2020 end-page: 36 ident: bib68 article-title: Intersection of the gut microbiome and circadian rhythms in metabolism publication-title: Trends Endocrinol. Metab. – volume: 19 start-page: 347 year: 2011 end-page: 358 ident: bib194 article-title: Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening publication-title: Cancer Cell – volume: 66 start-page: 724 year: 2017 end-page: 733 ident: bib201 article-title: The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction publication-title: J. Hepatol. – volume: 107 start-page: 14691 year: 2010 end-page: 14696 ident: bib44 article-title: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa publication-title: Proc. Natl. Acad. Sci. USA – volume: 124 start-page: 179 year: 1986 end-page: 185 ident: bib136 article-title: Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells publication-title: Am. J. Pathol. – volume: 6 start-page: 563 year: 2021 end-page: 573 ident: bib258 article-title: Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice publication-title: Nat. Microbiol. – volume: 33 start-page: 1073 year: 2021 end-page: 1075 ident: bib21 article-title: A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion publication-title: Cell Metab. – volume: 147 start-page: 629 year: 2011 end-page: 640 ident: bib132 article-title: Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation publication-title: Cell – volume: 28 start-page: 737 year: 2018 end-page: 749.e4 ident: bib163 article-title: Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome publication-title: Cell Metab. – volume: 5 start-page: 1507 year: 2021 end-page: 1517 ident: bib256 article-title: Obeticholic acid decreases intestinal content of Enterococcus in rats with cirrhosis and ascites publication-title: Hepatol. Commun. – volume: 47 start-page: 886 year: 2018 end-page: 895 ident: bib40 article-title: Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis publication-title: Aliment. Pharmacol. Ther. – volume: 12 start-page: 1851986 year: 2020 ident: bib84 article-title: The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation publication-title: Gut Microbes – volume: 24 start-page: 2050 year: 2010 end-page: 2064 ident: bib66 article-title: Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse publication-title: Mol. Endocrinol. – volume: 58 start-page: 949 year: 2013 end-page: 955 ident: bib107 article-title: Modulation of the fecal bile acid profile by gut microbiota in cirrhosis publication-title: J. Hepatol. – volume: 256 start-page: 167 year: 2019 end-page: 205 ident: bib79 article-title: Nonsteroidal FXR ligands: current status and clinical applications publication-title: Handb. Exp. Pharmacol. – volume: 33 start-page: 247 year: 2022 end-page: 265 ident: bib146 article-title: Gut barrier disruption and chronic disease publication-title: Trends Endocrinol. Metab. – volume: 123 start-page: 4799 year: 2013 end-page: 4808 ident: bib157 article-title: FGF19 action in the brain induces insulin-independent glucose lowering publication-title: J. Clin. Invest. – volume: 185 start-page: 831 year: 2022 end-page: 846.e14 ident: bib129 article-title: Mucosal fungi promote gut barrier function and social behavior via type 17 immunity publication-title: Cell – volume: 376 start-page: 1192 year: 2022 end-page: 1202 ident: bib3 article-title: Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice publication-title: Science – volume: 50 start-page: 1955 year: 2009 end-page: 1966 ident: bib32 article-title: Bile acids: regulation of synthesis publication-title: J. Lipid Res. – volume: 160 start-page: 206 year: 2021 end-page: 218.e13 ident: bib207 article-title: Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis publication-title: Gastroenterology – volume: 4 start-page: 492 year: 2019 end-page: 503 ident: bib162 article-title: Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis publication-title: Nat. Microbiol. – volume: 78 start-page: 597 year: 2020 end-page: 613 ident: bib131 article-title: Immune-microbiota interplay and colonization resistance in infection publication-title: Mol. Cell – volume: 72 start-page: 470 year: 2020 end-page: 485 ident: bib25 article-title: Increased liver localization of lipopolysaccharides in human and experimental NAFLD publication-title: Hepatology – volume: 180 start-page: 5653 year: 2008 end-page: 5661 ident: bib10 article-title: Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability publication-title: J. Immunol. – volume: 101 start-page: 683 year: 2021 end-page: 731 ident: bib177 article-title: Molecular physiology of bile acid signaling in health, disease, and aging publication-title: Physiol. Rev. – volume: 152 start-page: 1975 year: 2017 end-page: 1984.e8 ident: bib249 article-title: Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis publication-title: Gastroenterology – volume: 47 start-page: 238 year: 2018 end-page: 245 ident: bib166 article-title: Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients publication-title: Aliment. Pharmacol. Ther. – volume: 576 start-page: 143 year: 2019 end-page: 148 ident: bib89 article-title: Bile acid metabolites control TH17 and Treg cell differentiation publication-title: Nature – volume: 71 start-page: 1216 year: 2019 end-page: 1228 ident: bib158 article-title: Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development publication-title: J. Hepatol. – volume: 2 start-page: 1034 year: 2020 end-page: 1045 ident: bib223 article-title: Fructose stimulated de novo lipogenesis is promoted by inflammation publication-title: Nat. Metab. – volume: 151 start-page: 845 year: 2016 end-page: 859 ident: bib82 article-title: An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease publication-title: Gastroenterology – volume: 577 start-page: 410 year: 2020 end-page: 415 ident: bib208 article-title: Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis publication-title: Nature – volume: 68 start-page: 1477 year: 2019 end-page: 1492 ident: bib134 article-title: Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis publication-title: Gut – volume: 4 start-page: 416 year: 2022 end-page: 423 ident: bib176 article-title: Metabolic messengers: bile acids publication-title: Nat. Metab. – volume: 132 start-page: 41 year: 2012 end-page: 47 ident: bib153 article-title: Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19 publication-title: J. Steroid Biochem. Mol. Biol. – volume: 62 start-page: S25 year: 2015 end-page: S37 ident: bib17 article-title: New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond publication-title: J. Hepatol. – volume: 13 start-page: 1324 year: 2007 end-page: 1332 ident: bib203 article-title: TLR4 enhances TGF-beta signaling and hepatic fibrosis publication-title: Nat. Med. – volume: 24 start-page: 103092 year: 2021 ident: bib67 article-title: The gut microbiota instructs the hepatic endothelial cell transcriptome publication-title: iScience – volume: 75 start-page: 12 year: 2021 end-page: 15 ident: bib118 article-title: FXR agonists for NASH: how are they different and what difference do they make? publication-title: J. Hepatol. – volume: 603 start-page: 907 year: 2022 end-page: 912 ident: bib169 article-title: Human gut bacteria produce TauEta17-modulating bile acid metabolites publication-title: Nature – volume: 22 start-page: 287 year: 2021 end-page: 300 ident: bib217 article-title: Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes publication-title: Nat. Immunol. – volume: 26 start-page: 1183 year: 2015 end-page: 1192 ident: bib204 article-title: Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time publication-title: J. Nutr. Biochem. – volume: 37 start-page: 1043 year: 2003 end-page: 1055 ident: bib168 article-title: Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells publication-title: Hepatology – volume: 55 start-page: 1553 year: 2014 end-page: 1595 ident: bib95 article-title: Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades publication-title: J. Lipid Res. – volume: 107 start-page: 29 year: 2022 end-page: 38 ident: bib172 article-title: The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD publication-title: J. Clin. Endocrinol. Metab. – volume: 90 start-page: 1656 year: 2009 end-page: 1664 ident: bib239 article-title: A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome publication-title: Am. J. Clin. Nutr. – volume: 155 start-page: 1741 year: 2018 end-page: 1752.e5 ident: bib69 article-title: FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid publication-title: Gastroenterology – volume: 61 start-page: 883 year: 2015 end-page: 894 ident: bib30 article-title: Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice publication-title: Hepatology – volume: 26 start-page: 1652 year: 2020 end-page: 1657 ident: bib234 article-title: Variation in bile microbiome by the etiology of cholestatic liver disease publication-title: Liver Transpl. – volume: 16 start-page: 665 year: 2015 end-page: 674 ident: bib259 article-title: Does low-dose Rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study publication-title: J. Dig. Dis. – volume: 39 start-page: 371 year: 2019 end-page: 381 ident: bib53 article-title: Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis publication-title: Liver Int. – volume: 6 start-page: 1 year: 2015 end-page: 9 ident: bib124 article-title: Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice publication-title: Gut Microbes – volume: 513 start-page: 59 year: 2014 end-page: 64 ident: bib182 article-title: Alterations of the human gut microbiome in liver cirrhosis publication-title: Nature – volume: 110 start-page: 9066 year: 2013 end-page: 9071 ident: bib61 article-title: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity publication-title: Proc. Natl. Acad. Sci. USA – volume: 162 start-page: 1602 year: 2022 end-page: 1616.e6 ident: bib1 article-title: Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease publication-title: Gastroenterology – volume: 165 start-page: 111 year: 2016 end-page: 124 ident: bib267 article-title: Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk publication-title: Cell – volume: 185 start-page: 409 year: 2015 end-page: 419 ident: bib242 article-title: The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats publication-title: Am. J. Pathol. – volume: 70 start-page: 151 year: 2019 end-page: 171 ident: bib13 article-title: Burden of liver diseases in the world publication-title: J. Hepatol. – volume: 548 start-page: 111618 year: 2022 ident: bib33 article-title: Discovery of farnesoid X receptor and its role in bile acid metabolism publication-title: Mol. Cell. Endocrinol. – volume: 71 start-page: 1198 year: 2020 end-page: 1212 ident: bib90 article-title: NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis publication-title: Hepatology – volume: 29 start-page: 408 year: 2021 end-page: 424.e7 ident: bib28 article-title: A microbial metabolite remodels the gut-liver axis following bariatric surgery publication-title: Cell Host Microbe – volume: 13 start-page: 874 year: 2022 ident: bib34 article-title: IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence publication-title: Nat. Commun. – volume: 165 start-page: 1332 year: 2016 end-page: 1345 ident: bib115 article-title: From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites publication-title: Cell – volume: 67 start-page: 1298 year: 2017 end-page: 1323 ident: bib109 article-title: Primary sclerosing cholangitis - a comprehensive review publication-title: J. Hepatol. – volume: 63 start-page: 774 year: 1976 end-page: 778 ident: bib14 article-title: Endotoxin, bile salts and renal function in obstructive jaundice publication-title: Br. J. Surg. – volume: 1 start-page: 588 year: 2019 end-page: 594 ident: bib74 article-title: Metabolic messengers: fibroblast growth factor 15/19 publication-title: Nat. Metab. – volume: 21 start-page: 637 year: 2021 end-page: 652 ident: bib244 article-title: A guide to interrogating immunometabolism publication-title: Nat. Rev. Immunol. – volume: 39 start-page: 587 year: 1996 end-page: 593 ident: bib38 article-title: Role of the gut in the pathophysiology of extrahepatic biliary obstruction publication-title: Gut – volume: 114 start-page: 10178 year: 2017 end-page: 10183 ident: bib192 article-title: Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis publication-title: Proc. Natl. Acad. Sci. USA – volume: 582 start-page: 566 year: 2020 end-page: 570 ident: bib73 article-title: A metabolic pathway for bile acid dehydroxylation by the gut microbiome publication-title: Nature – volume: 137 start-page: 1716 year: 2009 end-page: 1724 ident: bib92 article-title: High-fat diet determines the composition of the murine gut microbiome independently of obesity publication-title: Gastroenterology – volume: 2 start-page: 1037 year: 2018 end-page: 1050 ident: bib148 article-title: NGM282 for treatment of patients with primary biliary cholangitis: a multicenter, randomized, double-blind, placebo-controlled trial publication-title: Hepatol. Commun. – volume: 158 start-page: 1948 year: 2020 end-page: 1966.e1 ident: bib191 article-title: Circadian rhythms in the pathogenesis and treatment of fatty liver disease publication-title: Gastroenterology – volume: 12 start-page: 1253 year: 2006 end-page: 1255 ident: bib35 article-title: Identification of a hormonal basis for gallbladder filling publication-title: Nat. Med. – volume: 341 start-page: 800 year: 2013 end-page: 802 ident: bib216 article-title: A gut lipid messenger links excess dietary fat to dopamine deficiency publication-title: Science – volume: 334 start-page: 1561 year: 2011 end-page: 1565 ident: bib113 article-title: Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles publication-title: Science – volume: 585 start-page: 591 year: 2020 end-page: 596 ident: bib218 article-title: The liver-brain-gut neural arc maintains the Treg cell niche in the gut publication-title: Nature – volume: 594 start-page: 234 year: 2021 end-page: 239 ident: bib250 article-title: Reconstruction of ancient microbial genomes from the human gut publication-title: Nature – volume: 282 start-page: 2085 year: 1998 end-page: 2088 ident: bib179 article-title: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene publication-title: Science – volume: 332 start-page: 970 year: 2011 end-page: 974 ident: bib159 article-title: Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans publication-title: Science – volume: 56 start-page: 1761 year: 2007 end-page: 1772 ident: bib22 article-title: Metabolic endotoxemia initiates obesity and insulin resistance publication-title: Diabetes – volume: 28 start-page: 660 year: 2020 end-page: 668.e4 ident: bib150 article-title: Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection publication-title: Cell Host Microbe – volume: 245 start-page: 425 year: 2020 end-page: 437 ident: bib50 article-title: SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD publication-title: J. Endocrinol. – volume: 167 start-page: 1071 year: 2005 end-page: 1079 ident: bib156 article-title: Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats publication-title: Am. J. Pathol. – volume: 136 start-page: 1435 year: 2009 end-page: 1443 ident: bib39 article-title: Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium publication-title: Gastroenterology – volume: 33 start-page: 791 year: 2021 end-page: 803.e7 ident: bib264 article-title: Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism publication-title: Cell Metab. – volume: 49 start-page: 1228 year: 2009 end-page: 1235 ident: bib195 article-title: High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis publication-title: Hepatology – volume: 487 start-page: 104 year: 2012 end-page: 108 ident: bib52 article-title: Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice publication-title: Nature – volume: 71 start-page: 1020 year: 2022 end-page: 1032 ident: bib46 article-title: Gut microbiome and health: mechanistic insights publication-title: Gut – volume: 322 start-page: G473 year: 2022 end-page: G479 ident: bib106 article-title: Revisiting the gut-liver axis: gut lymphatic system in liver cirrhosis and portal hypertension publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. – volume: 69 start-page: 1483 year: 2020 end-page: 1491 ident: bib209 article-title: Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease publication-title: Gut – volume: 42 start-page: 802 year: 2015 end-page: 817 ident: bib174 article-title: Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence? publication-title: Aliment. Pharmacol. Ther. – volume: 21 start-page: 159 year: 2015 end-page: 165 ident: bib64 article-title: Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance publication-title: Nat. Med. – volume: 599 start-page: 458 year: 2021 end-page: 464 ident: bib193 article-title: Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians publication-title: Nature – volume: 23 start-page: 107 year: 2017 end-page: 113 ident: bib178 article-title: A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice publication-title: Nat. Med. – volume: 74 start-page: 1660 year: 2021 end-page: 1673 ident: bib24 article-title: The use of Rifaximin in patients with cirrhosis publication-title: Hepatology – volume: 587 start-page: 448 year: 2020 end-page: 454 ident: bib245 article-title: Host variables confound gut microbiota studies of human disease publication-title: Nature – volume: 4 start-page: 8 year: 1987 end-page: 14 ident: bib18 article-title: Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess publication-title: J. Hepatol. – volume: 18 start-page: 649 year: 2021 end-page: 667 ident: bib190 article-title: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 25 start-page: 1054 year: 2017 end-page: 1062.e5 ident: bib140 article-title: Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease publication-title: Cell Metab. – volume: 66 start-page: 613 year: 2017 end-page: 626 ident: bib254 article-title: An intestinal farnesoid X receptor-ceramide signaling axis modulates hepatic gluconeogenesis in mice publication-title: Diabetes – volume: 70 start-page: 761 year: 2021 end-page: 774 ident: bib261 article-title: Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites publication-title: Gut – volume: 47 start-page: 101183 year: 2021 ident: bib130 article-title: Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes publication-title: Diabetes Metab. – volume: 3 start-page: 1228 year: 2021 end-page: 1241 ident: bib200 article-title: Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling publication-title: Nat. Metab. – volume: 34 start-page: 510 year: 2022 end-page: 512 ident: bib268 article-title: Liver microbes controlling immunity: facts and pitfalls publication-title: Cell Metab. – volume: 108 start-page: 1083 year: 1995 end-page: 1087 ident: bib120 article-title: Effect of sulindac on sporadic colonic polyps publication-title: Gastroenterology – volume: 34 start-page: 101 year: 2001 end-page: 108 ident: bib236 article-title: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice publication-title: Hepatology – volume: 132 start-page: e151725 year: 2022 ident: bib127 article-title: Intrahepatic microbes govern liver immunity by programming NKT cells publication-title: J. Clin. Invest. – volume: 12 start-page: 17 year: 2018 end-page: 29 ident: bib170 article-title: Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features publication-title: Gut Liver – volume: 192 start-page: 629 year: 2022 end-page: 641 ident: bib238 article-title: Bile from patients with primary sclerosing cholangitis contains mucosal-associated invariant T-cell antigens publication-title: Am. J. Pathol. – volume: 166 start-page: 4737 year: 2001 end-page: 4742 ident: bib257 article-title: Reduced early alcohol-induced liver injury in CD14-deficient mice publication-title: J. Immunol. – volume: 114 start-page: 1071 year: 2019 end-page: 1079 ident: bib9 article-title: Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial publication-title: Am. J. Gastroenterol. – volume: 75 start-page: S67 year: 2021 end-page: S81 ident: bib229 article-title: The microbiota in cirrhosis and its role in hepatic decompensation publication-title: J. Hepatol. – volume: 14 start-page: 677 year: 2020 end-page: 689 ident: bib111 article-title: Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders publication-title: Hepatol. Int. – volume: 9 start-page: 1735 year: 2018 ident: bib114 article-title: beta-defensin 1 is prominent in the liver and induced during cholestasis by bilirubin and bile acids via farnesoid X receptor and constitutive androstane receptor publication-title: Front. Immunol. – volume: 4 start-page: 781 year: 2019 end-page: 793 ident: bib227 article-title: Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial publication-title: Lancet Gastroenterol. Hepatol. – volume: 519 start-page: 92 year: 2015 end-page: 96 ident: bib26 article-title: Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome publication-title: Nature – volume: 17 start-page: 1374 year: 2007 end-page: 1380 ident: bib189 article-title: Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis publication-title: Obes. Surg. – volume: 12 start-page: 1209 year: 2021 ident: bib104 article-title: Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation publication-title: Nat. Commun. – volume: 71 start-page: 522 year: 2020 end-page: 538 ident: bib122 article-title: Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis publication-title: Hepatology – volume: 338 start-page: 1423 year: 1991 end-page: 1424 ident: bib85 article-title: Production of interleukin-1-receptor antagonist during experimental endotoxaemia publication-title: Lancet – volume: 40 start-page: 111008 year: 2022 ident: bib41 article-title: Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome publication-title: Cell Rep. – volume: 17 start-page: 657 year: 2013 end-page: 669 ident: bib43 article-title: Pleiotropic roles of bile acids in metabolism publication-title: Cell Metab. – volume: 64 start-page: 2015 year: 2016 end-page: 2027 ident: bib128 article-title: Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis publication-title: Hepatology – volume: 9 start-page: 799 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib233 article-title: Intestinal mucosal barrier function in health and disease publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2653 – volume: 137 start-page: 1716 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib92 article-title: High-fat diet determines the composition of the murine gut microbiome independently of obesity publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.08.042 – volume: 12 start-page: 1859812 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib55 article-title: The aryl hydrocarbon receptor as a mediator of host-microbiota interplay publication-title: Gut Microbes doi: 10.1080/19490976.2020.1859812 – volume: 2 start-page: 100151 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib188 article-title: Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2020.100151 – volume: 49 start-page: 1877 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib152 article-title: Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.22848 – volume: 107 start-page: 14691 year: 2010 ident: 10.1016/j.cmet.2022.09.017_bib44 article-title: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1005963107 – volume: 32 start-page: 878 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib167 article-title: A universal gut-microbiome-derived signature predicts cirrhosis publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.06.005 – volume: 4 start-page: 416 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib176 article-title: Metabolic messengers: bile acids publication-title: Nat. Metab. doi: 10.1038/s42255-022-00559-z – volume: 377 start-page: eabp9960 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib126 article-title: The microbiome and gut homeostasis publication-title: Science doi: 10.1126/science.abp9960 – volume: 38 start-page: 104 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib135 article-title: Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again publication-title: Curr. Opin. Gastroenterol. doi: 10.1097/MOG.0000000000000809 – volume: 118 start-page: 476 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib76 article-title: Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet publication-title: J. Biosci. Bioeng. doi: 10.1016/j.jbiosc.2014.03.001 – volume: 22 start-page: 266 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib253 article-title: Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.06.007 – volume: 160 start-page: 206 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib207 article-title: Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.08.054 – volume: 6 start-page: 563 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib258 article-title: Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice publication-title: Nat. Microbiol. doi: 10.1038/s41564-021-00880-5 – volume: 21 start-page: 527 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib142 article-title: Regulation of obesity-related insulin resistance with gut anti-inflammatory agents publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.03.001 – volume: 594 start-page: 234 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib250 article-title: Reconstruction of ancient microbial genomes from the human gut publication-title: Nature doi: 10.1038/s41586-021-03532-0 – volume: 6 start-page: 19076 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib31 article-title: Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults publication-title: Sci. Rep. doi: 10.1038/srep19076 – volume: 25 start-page: 1243 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib117 article-title: Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.05.002 – volume: 28 start-page: 660 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib150 article-title: Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.07.014 – volume: 4 start-page: 8 year: 1987 ident: 10.1016/j.cmet.2022.09.017_bib18 article-title: Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess publication-title: J. Hepatol. doi: 10.1016/S0168-8278(87)80003-X – volume: 28 start-page: 907 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib62 article-title: Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements publication-title: Cell Metab. doi: 10.1016/j.cmet.2018.08.005 – volume: 65 start-page: 1579 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib108 article-title: Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love? publication-title: Gut doi: 10.1136/gutjnl-2016-312137 – volume: 185 start-page: 379 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib87 article-title: Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches publication-title: Cell doi: 10.1016/j.cell.2021.12.018 – volume: 70 start-page: 761 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib261 article-title: Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites publication-title: Gut doi: 10.1136/gutjnl-2019-319664 – volume: 12 start-page: 1209 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib104 article-title: Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation publication-title: Nat. Commun. doi: 10.1038/s41467-021-21461-4 – volume: 58 start-page: 949 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib107 article-title: Modulation of the fecal bile acid profile by gut microbiota in cirrhosis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2013.01.003 – volume: 32 start-page: 742 year: 2000 ident: 10.1016/j.cmet.2022.09.017_bib171 article-title: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease publication-title: J. Hepatol. doi: 10.1016/S0168-8278(00)80242-1 – volume: 123 start-page: 4799 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib157 article-title: FGF19 action in the brain induces insulin-independent glucose lowering publication-title: J. Clin. Invest. doi: 10.1172/JCI70710 – volume: 29 start-page: 221 year: 1986 ident: 10.1016/j.cmet.2022.09.017_bib155 article-title: Abnormal intestinal permeability to sugars in diabetes mellitus publication-title: Diabetologia doi: 10.1007/BF00454879 – volume: 585 start-page: 591 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib218 article-title: The liver-brain-gut neural arc maintains the Treg cell niche in the gut publication-title: Nature doi: 10.1038/s41586-020-2425-3 – volume: 63 start-page: 774 year: 1976 ident: 10.1016/j.cmet.2022.09.017_bib14 article-title: Endotoxin, bile salts and renal function in obstructive jaundice publication-title: Br. J. Surg. doi: 10.1002/bjs.1800631011 – volume: 399 start-page: 61 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib110 article-title: The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality publication-title: Lancet doi: 10.1016/S0140-6736(21)01701-3 – volume: 47 start-page: 101183 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib130 article-title: Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes publication-title: Diabetes Metab. doi: 10.1016/j.diabet.2020.07.010 – volume: 50 start-page: 645 year: 2010 ident: 10.1016/j.cmet.2022.09.017_bib8 article-title: Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children publication-title: J. Pediatr. Gastroenterol. Nutr. doi: 10.1097/MPG.0b013e3181c7bdf1 – volume: 37 start-page: 551 year: 2003 ident: 10.1016/j.cmet.2022.09.017_bib141 article-title: Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats publication-title: Hepatology doi: 10.1053/jhep.2003.50116 – volume: 12 start-page: 1253 year: 2006 ident: 10.1016/j.cmet.2022.09.017_bib35 article-title: Identification of a hormonal basis for gallbladder filling publication-title: Nat. Med. doi: 10.1038/nm1501 – volume: 110 start-page: 515 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib80 article-title: Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice publication-title: Br. J. Nutr. doi: 10.1017/S0007114512005326 – volume: 42 start-page: 802 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib174 article-title: Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence? publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.13333 – volume: 595 start-page: 272 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib243 article-title: Caloric restriction disrupts the microbiota and colonization resistance publication-title: Nature doi: 10.1038/s41586-021-03663-4 – volume: 245 start-page: 425 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib50 article-title: SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD publication-title: J. Endocrinol. doi: 10.1530/JOE-20-0018 – volume: 26 start-page: 1183 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib204 article-title: Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time publication-title: J. Nutr. Biochem. doi: 10.1016/j.jnutbio.2015.05.011 – volume: 587 start-page: 448 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib245 article-title: Host variables confound gut microbiota studies of human disease publication-title: Nature doi: 10.1038/s41586-020-2881-9 – volume: 70 start-page: 483 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib93 article-title: Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.10.035 – volume: 18 start-page: 167 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib228 article-title: Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-00376-3 – volume: 582 start-page: 566 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib73 article-title: A metabolic pathway for bile acid dehydroxylation by the gut microbiome publication-title: Nature doi: 10.1038/s41586-020-2396-4 – volume: 24 start-page: 1070 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib98 article-title: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women publication-title: Nat. Med. doi: 10.1038/s41591-018-0061-3 – volume: 72 start-page: 391 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib37 article-title: The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.09.029 – volume: 22 start-page: 287 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib217 article-title: Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes publication-title: Nat. Immunol. doi: 10.1038/s41590-021-00867-8 – volume: 40 start-page: 751 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib260 article-title: Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-kappaB (nuclear factor kappa B) signals publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.119.313414 – volume: 64 start-page: 2015 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib128 article-title: Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis publication-title: Hepatology doi: 10.1002/hep.28829 – volume: 165 start-page: 1332 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib115 article-title: From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites publication-title: Cell doi: 10.1016/j.cell.2016.05.041 – volume: 579 start-page: 586 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib263 article-title: Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate publication-title: Nature doi: 10.1038/s41586-020-2101-7 – volume: 47 start-page: 238 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib166 article-title: Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.14393 – volume: 175 start-page: 400 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib45 article-title: Self-maintaining gut macrophages are essential for intestinal homeostasis publication-title: Cell doi: 10.1016/j.cell.2018.07.048 – volume: 65 start-page: 1393 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib226 article-title: New therapeutic concepts in bile acid transport and signaling for management of cholestasis publication-title: Hepatology doi: 10.1002/hep.28991 – volume: 67 start-page: 891 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib83 article-title: Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease publication-title: Gut doi: 10.1136/gutjnl-2016-313432 – volume: 11 start-page: 1329 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib96 article-title: Perivascular localization of macrophages in the intestinal mucosa is regulated by Nr4a1 and the microbiome publication-title: Nat. Commun. doi: 10.1038/s41467-020-15068-4 – volume: 4 start-page: 2384 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib133 article-title: Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity publication-title: Nat. Commun. doi: 10.1038/ncomms3384 – volume: 108 start-page: 1083 year: 1995 ident: 10.1016/j.cmet.2022.09.017_bib120 article-title: Effect of sulindac on sporadic colonic polyps publication-title: Gastroenterology doi: 10.1016/0016-5085(95)90206-6 – volume: 158 start-page: 2266 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib262 article-title: TMAVA, a metabolite of intestinal microbes, is increased in plasma from patients with liver steatosis, inhibits gamma-butyrobetaine hydroxylase, and exacerbates fatty liver in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.02.033 – volume: 75 start-page: 12 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib118 article-title: FXR agonists for NASH: how are they different and what difference do they make? publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.03.020 – volume: 70 start-page: 522 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib70 article-title: Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function publication-title: Gut doi: 10.1136/gutjnl-2020-322753 – volume: 14 start-page: 2029674 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib78 article-title: Circulating microbiome in patients with portal hypertension publication-title: Gut Microbes doi: 10.1080/19490976.2022.2029674 – volume: 192 start-page: 629 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib238 article-title: Bile from patients with primary sclerosing cholangitis contains mucosal-associated invariant T-cell antigens publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2021.12.008 – volume: 114 start-page: 10178 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib192 article-title: Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1712837114 – volume: 33 start-page: 247 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib146 article-title: Gut barrier disruption and chronic disease publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2022.01.002 – volume: 73 start-page: 1061 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib49 article-title: Oral vancomycin, ursodeoxycholic acid, or no therapy for pediatric primary sclerosing cholangitis: a matched analysis publication-title: Hepatology doi: 10.1002/hep.31560 – volume: 124 start-page: 179 year: 1986 ident: 10.1016/j.cmet.2022.09.017_bib136 article-title: Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells publication-title: Am. J. Pathol. – volume: 89 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib75 article-title: Bile salts differentially enhance resistance of enterohemorrhagic Escherichia coli O157:H7 to host defense peptides publication-title: Infect. Immun. doi: 10.1128/IAI.00719-20 – volume: 151 start-page: 845 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib82 article-title: An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.08.057 – volume: 155 start-page: 1741 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib69 article-title: FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.022 – volume: 70 start-page: 1299 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib251 article-title: Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury publication-title: Gut doi: 10.1136/gutjnl-2020-321565 – volume: 69 start-page: 1483 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib209 article-title: Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease publication-title: Gut doi: 10.1136/gutjnl-2019-318811 – volume: 147 start-page: 629 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib132 article-title: Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation publication-title: Cell doi: 10.1016/j.cell.2011.09.025 – volume: 73 start-page: 968 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib7 article-title: Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults publication-title: Hepatology doi: 10.1002/hep.31417 – volume: 18 start-page: 649 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib190 article-title: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00440-6 – volume: 75 start-page: 1095 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib186 article-title: Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance publication-title: Hepatology doi: 10.1002/hep.32289 – volume: 575 start-page: 505 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib57 article-title: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease publication-title: Nature doi: 10.1038/s41586-019-1742-x – volume: 350 start-page: 830 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib211 article-title: A gut-vascular barrier controls the systemic dissemination of bacteria publication-title: Science doi: 10.1126/science.aad0135 – volume: 152 start-page: 1975 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib249 article-title: Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.02.038 – volume: 2 start-page: 1034 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib223 article-title: Fructose stimulated de novo lipogenesis is promoted by inflammation publication-title: Nat. Metab. doi: 10.1038/s42255-020-0261-2 – volume: 160 start-page: 219 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib91 article-title: Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.08.004 – volume: 3 start-page: 1596 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib222 article-title: Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity publication-title: Nat. Metab. doi: 10.1038/s42255-021-00501-9 – volume: 62 start-page: 1398 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib160 article-title: Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.12.034 – volume: 66 start-page: 613 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib254 article-title: An intestinal farnesoid X receptor-ceramide signaling axis modulates hepatic gluconeogenesis in mice publication-title: Diabetes doi: 10.2337/db16-0663 – volume: 12 start-page: 41 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib77 article-title: Machine learning applied to omics datasets predicts mortality in patients with alcoholic hepatitis publication-title: Metabolites doi: 10.3390/metabo12010041 – volume: 112 start-page: 137 year: 1999 ident: 10.1016/j.cmet.2022.09.017_bib198 article-title: Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6 publication-title: J. Cell Sci. doi: 10.1242/jcs.112.1.137 – volume: 5 start-page: e143 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib6 article-title: Excess dietary fructose does not alter gut microbiota or permeability in humans: a pilot randomized controlled study publication-title: J. Clin. Transl. Sci. doi: 10.1017/cts.2021.801 – volume: 68 start-page: 578 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib197 article-title: Circulating microbiome in blood of different circulatory compartments publication-title: Gut doi: 10.1136/gutjnl-2018-316227 – volume: 70 start-page: 151 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib13 article-title: Burden of liver diseases in the world publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.09.014 – volume: 47 start-page: 886 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib40 article-title: Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.14540 – volume: 3 start-page: 1228 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib200 article-title: Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling publication-title: Nat. Metab. doi: 10.1038/s42255-021-00452-1 – volume: 86 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib112 article-title: Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis publication-title: Appl. Environ. Microbiol. doi: 10.1128/AEM.03004-19 – volume: 74 start-page: 1660 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib24 article-title: The use of Rifaximin in patients with cirrhosis publication-title: Hepatology doi: 10.1002/hep.31708 – volume: 3 start-page: 100220 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib63 article-title: Gut dysbiosis as a driver in alcohol-induced liver injury publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2020.100220 – volume: 12 start-page: 162 year: 1991 ident: 10.1016/j.cmet.2022.09.017_bib72 article-title: Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay publication-title: J. Hepatol. doi: 10.1016/0168-8278(91)90933-3 – volume: 166 start-page: 4737 year: 2001 ident: 10.1016/j.cmet.2022.09.017_bib257 article-title: Reduced early alcohol-induced liver injury in CD14-deficient mice publication-title: J. Immunol. doi: 10.4049/jimmunol.166.7.4737 – volume: 49 start-page: 1228 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib195 article-title: High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis publication-title: Hepatology doi: 10.1002/hep.22771 – volume: 599 start-page: 458 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib193 article-title: Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians publication-title: Nature doi: 10.1038/s41586-021-03832-5 – volume: 71 start-page: 1020 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib46 article-title: Gut microbiome and health: mechanistic insights publication-title: Gut doi: 10.1136/gutjnl-2021-326789 – volume: 1 start-page: 588 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib74 article-title: Metabolic messengers: fibroblast growth factor 15/19 publication-title: Nat. Metab. doi: 10.1038/s42255-019-0074-3 – volume: 322 start-page: G473 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib106 article-title: Revisiting the gut-liver axis: gut lymphatic system in liver cirrhosis and portal hypertension publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.00271.2021 – volume: 182 start-page: 1441 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib231 article-title: Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis publication-title: Cell doi: 10.1016/j.cell.2020.08.027 – volume: 334 start-page: 1561 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib113 article-title: Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles publication-title: Science doi: 10.1126/science.1214914 – volume: 4 start-page: 492 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib162 article-title: Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis publication-title: Nat. Microbiol. doi: 10.1038/s41564-018-0333-1 – volume: 62 start-page: S25 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib17 article-title: New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.02.023 – volume: 37 start-page: 314 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib97 article-title: The microbiome in primary sclerosing cholangitis: current evidence and potential concepts publication-title: Semin. Liver Dis. doi: 10.1055/s-0037-1608801 – volume: 5 start-page: e138881 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib266 article-title: Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding publication-title: JCI Insight doi: 10.1172/jci.insight.138881 – volume: 33 start-page: 1073 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib21 article-title: A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion publication-title: Cell Metab. doi: 10.1016/j.cmet.2021.05.004 – volume: 19 start-page: 60 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib125 article-title: Advancing the global public health agenda for NAFLD: a consensus statement publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00523-4 – volume: 34 start-page: 510 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib268 article-title: Liver microbes controlling immunity: facts and pitfalls publication-title: Cell Metab. doi: 10.1016/j.cmet.2022.03.001 – volume: 487 start-page: 104 year: 2012 ident: 10.1016/j.cmet.2022.09.017_bib52 article-title: Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice publication-title: Nature doi: 10.1038/nature11225 – volume: 71 start-page: 1198 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib90 article-title: NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.30590 – volume: 25 start-page: 1885 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib202 article-title: Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression publication-title: Nat. Med. doi: 10.1038/s41591-019-0660-7 – volume: 548 start-page: 111618 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib33 article-title: Discovery of farnesoid X receptor and its role in bile acid metabolism publication-title: Mol. Cell. Endocrinol. doi: 10.1016/j.mce.2022.111618 – volume: 14 start-page: 390 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib12 article-title: Glucagon-like peptide 1 in health and disease publication-title: Nat. Rev. Endocrinol. doi: 10.1038/s41574-018-0016-2 – volume: 68 start-page: 1574 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib173 article-title: Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism publication-title: Hepatology doi: 10.1002/hep.29857 – volume: 90 start-page: 1656 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib239 article-title: A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.2009.27792 – volume: 50 start-page: 1955 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib32 article-title: Bile acids: regulation of synthesis publication-title: J. Lipid Res. doi: 10.1194/jlr.R900010-JLR200 – volume: 595 start-page: 91 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib47 article-title: Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans publication-title: Nature doi: 10.1038/s41586-021-03671-4 – volume: 69 start-page: 1346 year: 1975 ident: 10.1016/j.cmet.2022.09.017_bib165 article-title: The role of endotoxin in liver injury publication-title: Gastroenterology doi: 10.1016/S0016-5085(19)32333-9 – volume: 256 start-page: 167 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib79 article-title: Nonsteroidal FXR ligands: current status and clinical applications publication-title: Handb. Exp. Pharmacol. doi: 10.1007/164_2019_232 – volume: 24 start-page: 1919 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib213 article-title: Gut microbiota and intestinal FXR mediate the clinical benefits of metformin publication-title: Nat. Med. doi: 10.1038/s41591-018-0222-4 – volume: 103 start-page: 4333 year: 2006 ident: 10.1016/j.cmet.2022.09.017_bib94 article-title: How bile acids confer gut mucosal protection against bacteria publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0600780103 – volume: 75 start-page: S67 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib229 article-title: The microbiota in cirrhosis and its role in hepatic decompensation publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.11.013 – volume: 4 start-page: 781 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib227 article-title: Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(19)30184-0 – volume: 24 start-page: 2050 year: 2010 ident: 10.1016/j.cmet.2022.09.017_bib66 article-title: Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse publication-title: Mol. Endocrinol. doi: 10.1210/me.2010-0142 – volume: 37 start-page: 1043 year: 2003 ident: 10.1016/j.cmet.2022.09.017_bib168 article-title: Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells publication-title: Hepatology doi: 10.1053/jhep.2003.50182 – volume: 66 start-page: 724 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib201 article-title: The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.12.005 – volume: 57 start-page: 1470 year: 2008 ident: 10.1016/j.cmet.2022.09.017_bib23 article-title: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice publication-title: Diabetes doi: 10.2337/db07-1403 – volume: 1 start-page: 6ra14 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib232 article-title: The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3000322 – volume: 1 start-page: 222 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib143 article-title: Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability publication-title: Cell. Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2015.01.001 – volume: 162 start-page: 1602 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib1 article-title: Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.12.288 – volume: 132 start-page: e151725 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib127 article-title: Intrahepatic microbes govern liver immunity by programming NKT cells publication-title: J. Clin. Invest. doi: 10.1172/JCI151725 – volume: 13 start-page: 814692 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib151 article-title: Destination and specific impact of different bile acids in the intestinal pathogen Clostridioides difficile publication-title: Front. Microbiol. doi: 10.3389/fmicb.2022.814692 – volume: 78 start-page: 597 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib131 article-title: Immune-microbiota interplay and colonization resistance in infection publication-title: Mol. Cell doi: 10.1016/j.molcel.2020.03.001 – volume: 70 start-page: 982 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib225 article-title: Targeting the gut-liver-immune axis to treat cirrhosis publication-title: Gut doi: 10.1136/gutjnl-2020-320786 – volume: 67 start-page: 1881 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib101 article-title: Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD publication-title: Gut doi: 10.1136/gutjnl-2017-314307 – volume: 334 start-page: 105 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib252 article-title: Linking long-term dietary patterns with gut microbial enterotypes publication-title: Science doi: 10.1126/science.1208344 – volume: 55 start-page: 1553 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib95 article-title: Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades publication-title: J. Lipid Res. doi: 10.1194/jlr.R049437 – volume: 14 start-page: 279 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib100 article-title: Genetics of primary sclerosing cholangitis and pathophysiological implications publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2016.154 – volume: 19 start-page: 432 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib71 article-title: Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00566-7 – volume: 2020 start-page: 6672636 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib248 article-title: High-fructose diet increases inflammatory cytokines and alters gut microbiota composition in rats publication-title: Mediators Inflamm. doi: 10.1155/2020/6672636 – volume: 24 start-page: 41 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib246 article-title: Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism publication-title: Cell Metab. doi: 10.1016/j.cmet.2016.05.005 – volume: 341 start-page: 800 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib216 article-title: A gut lipid messenger links excess dietary fat to dopamine deficiency publication-title: Science doi: 10.1126/science.1239275 – volume: 576 start-page: 143 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib89 article-title: Bile acid metabolites control TH17 and Treg cell differentiation publication-title: Nature doi: 10.1038/s41586-019-1785-z – volume: 159 start-page: 1290 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib123 article-title: Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.06.006 – volume: 61 start-page: 883 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib30 article-title: Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice publication-title: Hepatology doi: 10.1002/hep.27489 – volume: 185 start-page: 831 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib129 article-title: Mucosal fungi promote gut barrier function and social behavior via type 17 immunity publication-title: Cell doi: 10.1016/j.cell.2022.01.017 – volume: 62 start-page: 899 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib237 article-title: Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice publication-title: Gut doi: 10.1136/gutjnl-2012-302945 – volume: 591 start-page: 633 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib185 article-title: Multi-kingdom ecological drivers of microbiota assembly in preterm infants publication-title: Nature doi: 10.1038/s41586-021-03241-8 – volume: 341 start-page: 569 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib206 article-title: The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis publication-title: Science doi: 10.1126/science.1241165 – volume: 25 start-page: 1096 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib51 article-title: Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study publication-title: Nat. Med. doi: 10.1038/s41591-019-0495-2 – volume: 24 start-page: 103092 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib67 article-title: The gut microbiota instructs the hepatic endothelial cell transcriptome publication-title: iScience doi: 10.1016/j.isci.2021.103092 – volume: 72 start-page: 558 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib5 article-title: The gut-liver axis in liver disease: pathophysiological basis for therapy publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.10.003 – volume: 9 start-page: 1735 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib114 article-title: beta-defensin 1 is prominent in the liver and induced during cholestasis by bilirubin and bile acids via farnesoid X receptor and constitutive androstane receptor publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01735 – volume: 71 start-page: 522 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib122 article-title: Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis publication-title: Hepatology doi: 10.1002/hep.30832 – volume: 83 start-page: 724 year: 1989 ident: 10.1016/j.cmet.2022.09.017_bib144 article-title: Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers publication-title: J. Clin. Invest. doi: 10.1172/JCI113938 – volume: 13 start-page: 233 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib181 article-title: Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease publication-title: Cell. Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2021.08.014 – volume: 278 start-page: 11312 year: 2003 ident: 10.1016/j.cmet.2022.09.017_bib19 article-title: The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids publication-title: J. Biol. Chem. doi: 10.1074/jbc.M211609200 – volume: 36 start-page: e22174 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib102 article-title: Colonic interleukin-22 protects intestinal mucosal barrier and microbiota abundance in severe acute pancreatitis publication-title: FASEB J. doi: 10.1096/fj.202101371R – volume: 34 start-page: 101 year: 2001 ident: 10.1016/j.cmet.2022.09.017_bib236 article-title: Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice publication-title: Hepatology doi: 10.1053/jhep.2001.25350 – volume: 519 start-page: 92 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib26 article-title: Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome publication-title: Nature doi: 10.1038/nature14232 – volume: 505 start-page: 559 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib42 article-title: Diet rapidly and reproducibly alters the human gut microbiome publication-title: Nature doi: 10.1038/nature12820 – volume: 13 start-page: 729 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib180 article-title: FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1alpha pathway publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.03.019 – volume: 74 start-page: 3306 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib265 article-title: Separating tumorigenicity from bile acid regulatory activity for endocrine hormone FGF19 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0208 – volume: 513 start-page: 59 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib182 article-title: Alterations of the human gut microbiome in liver cirrhosis publication-title: Nature doi: 10.1038/nature13568 – volume: 13 start-page: 1324 year: 2007 ident: 10.1016/j.cmet.2022.09.017_bib203 article-title: TLR4 enhances TGF-beta signaling and hepatic fibrosis publication-title: Nat. Med. doi: 10.1038/nm1663 – volume: 368 start-page: 1575 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib215 article-title: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1109400 – volume: 338 start-page: 1423 year: 1991 ident: 10.1016/j.cmet.2022.09.017_bib85 article-title: Production of interleukin-1-receptor antagonist during experimental endotoxaemia publication-title: Lancet doi: 10.1016/0140-6736(91)92725-H – volume: 14 start-page: 677 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib111 article-title: Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders publication-title: Hepatol. Int. doi: 10.1007/s12072-020-10070-w – volume: 70 start-page: 1174 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib4 article-title: Gut microbiota-derived metabolites as central regulators in metabolic disorders publication-title: Gut doi: 10.1136/gutjnl-2020-323071 – volume: 54 start-page: 562 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib29 article-title: Characterization of fecal microbial communities in patients with liver cirrhosis publication-title: Hepatology doi: 10.1002/hep.24423 – volume: 63 start-page: 185 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib214 article-title: Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis publication-title: Hepatology doi: 10.1002/hep.27927 – volume: 12 start-page: 1851986 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib84 article-title: The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation publication-title: Gut Microbes doi: 10.1080/19490976.2020.1851986 – volume: 23 start-page: 705 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib145 article-title: The impact of dietary fiber on gut microbiota in host health and disease publication-title: Cell Host Microbe doi: 10.1016/j.chom.2018.05.012 – volume: 21 start-page: 159 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib64 article-title: Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance publication-title: Nat. Med. doi: 10.1038/nm.3760 – volume: 23 start-page: 458 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib147 article-title: Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids publication-title: Cell Host Microbe doi: 10.1016/j.chom.2018.03.011 – volume: 26 start-page: 1652 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib234 article-title: Variation in bile microbiome by the etiology of cholestatic liver disease publication-title: Liver Transpl. doi: 10.1002/lt.25882 – volume: 359 start-page: 1376 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib219 article-title: Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection publication-title: Science doi: 10.1126/science.aar3318 – volume: 289 start-page: 340 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib240 article-title: A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study publication-title: J. Intern. Med. doi: 10.1111/joim.13157 – volume: 167 start-page: 1071 year: 2005 ident: 10.1016/j.cmet.2022.09.017_bib156 article-title: Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)61196-0 – volume: 39 start-page: 432 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib205 article-title: Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis publication-title: Semin. Liver Dis. doi: 10.1055/s-0039-1688501 – volume: 332 start-page: 970 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib159 article-title: Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans publication-title: Science doi: 10.1126/science.1198719 – volume: 21 start-page: 637 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib244 article-title: A guide to interrogating immunometabolism publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-021-00529-8 – volume: 107 start-page: 29 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib172 article-title: The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/clinem/dgab578 – volume: 6 start-page: 1 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib124 article-title: Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice publication-title: Gut Microbes doi: 10.4161/19490976.2014.990784 – volume: 16 start-page: 665 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib259 article-title: Does low-dose Rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study publication-title: J. Dig. Dis. doi: 10.1111/1751-2980.12294 – volume: 20 start-page: 40 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib221 article-title: The intestinal microbiota fuelling metabolic inflammation publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-019-0198-4 – volume: 76 start-page: 788 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib48 article-title: The fecal mycobiome in non-alcoholic fatty liver disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.11.029 – volume: 577 start-page: 410 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib208 article-title: Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis publication-title: Nature doi: 10.1038/s41586-019-1865-0 – volume: 581 start-page: 475 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib20 article-title: Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells publication-title: Nature doi: 10.1038/s41586-020-2193-0 – volume: 579 start-page: 123 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib183 article-title: Global chemical effects of the microbiome include new bile-acid conjugations publication-title: Nature doi: 10.1038/s41586-020-2047-9 – volume: 17 start-page: 1374 year: 2007 ident: 10.1016/j.cmet.2022.09.017_bib189 article-title: Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis publication-title: Obes. Surg. doi: 10.1007/s11695-007-9243-7 – volume: 12 start-page: 7172 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib58 article-title: CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease publication-title: Nat. Commun. doi: 10.1038/s41467-021-27385-3 – volume: 178 start-page: 1102 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib105 article-title: Dietary intake regulates the circulating inflammatory monocyte pool publication-title: Cell doi: 10.1016/j.cell.2019.07.050 – volume: 47 start-page: 241 year: 2006 ident: 10.1016/j.cmet.2022.09.017_bib187 article-title: Bile salt biotransformations by human intestinal bacteria publication-title: J. Lipid Res. doi: 10.1194/jlr.R500013-JLR200 – volume: 132 start-page: 41 year: 2012 ident: 10.1016/j.cmet.2022.09.017_bib153 article-title: Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19 publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2012.04.008 – volume: 19 start-page: 347 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib194 article-title: Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.01.040 – volume: 70 start-page: 925 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib161 article-title: Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis publication-title: Hepatology doi: 10.1002/hep.30349 – volume: 49 start-page: 636 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib212 article-title: Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/apt.15148 – volume: 180 start-page: 5653 year: 2008 ident: 10.1016/j.cmet.2022.09.017_bib10 article-title: Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability publication-title: J. Immunol. doi: 10.4049/jimmunol.180.8.5653 – volume: 71 start-page: 1216 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib158 article-title: Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.08.005 – volume: 101 start-page: 683 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib177 article-title: Molecular physiology of bile acid signaling in health, disease, and aging publication-title: Physiol. Rev. doi: 10.1152/physrev.00049.2019 – volume: 28 start-page: 737 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib163 article-title: Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome publication-title: Cell Metab. doi: 10.1016/j.cmet.2018.07.001 – volume: 33 start-page: 791 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib264 article-title: Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.11.017 – volume: 103 start-page: 3920 year: 2006 ident: 10.1016/j.cmet.2022.09.017_bib99 article-title: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0509592103 – volume: 17 start-page: 657 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib43 article-title: Pleiotropic roles of bile acids in metabolism publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.03.013 – volume: 165 start-page: 111 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib267 article-title: Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk publication-title: Cell doi: 10.1016/j.cell.2016.02.011 – volume: 41 start-page: 461 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib184 article-title: Role of FXR in bile acid and metabolic homeostasis in NASH: pathogenetic concepts and therapeutic opportunities publication-title: Semin. Liver Dis. doi: 10.1055/s-0041-1731707 – volume: 69 start-page: 665 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib138 article-title: Alterations of the bile microbiome in primary sclerosing cholangitis publication-title: Gut doi: 10.1136/gutjnl-2019-318416 – volume: 23 start-page: 1298 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib255 article-title: Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis publication-title: Nat. Med. doi: 10.1038/nm.4412 – volume: 25 start-page: 1054 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib140 article-title: Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.04.001 – volume: 29 start-page: 211 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib54 article-title: The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity publication-title: Cell Metab. doi: 10.1016/j.cmet.2018.09.003 – volume: 86 start-page: 1286 year: 2007 ident: 10.1016/j.cmet.2022.09.017_bib60 article-title: A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/86.5.1286 – volume: 67 start-page: 1298 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib109 article-title: Primary sclerosing cholangitis - a comprehensive review publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.07.022 – volume: 56 start-page: 1761 year: 2007 ident: 10.1016/j.cmet.2022.09.017_bib22 article-title: Metabolic endotoxemia initiates obesity and insulin resistance publication-title: Diabetes doi: 10.2337/db06-1491 – volume: 33 start-page: 2316 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib65 article-title: "Sweet death": fructose as a metabolic toxin that targets the gut-liver axis publication-title: Cell Metab. doi: 10.1016/j.cmet.2021.09.004 – volume: 175 start-page: 947 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib116 article-title: Microbially produced imidazole propionate impairs insulin signaling through mTORC1 publication-title: Cell doi: 10.1016/j.cell.2018.09.055 – volume: 376 start-page: 1192 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib3 article-title: Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice publication-title: Science doi: 10.1126/science.abk0297 – volume: 142 start-page: 1100 year: 2012 ident: 10.1016/j.cmet.2022.09.017_bib175 article-title: A high-fat diet is associated with endotoxemia that originates from the gut publication-title: Gastroenterology doi: 10.1053/j.gastro.2012.01.034 – volume: 603 start-page: 907 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib169 article-title: Human gut bacteria produce TauEta17-modulating bile acid metabolites publication-title: Nature doi: 10.1038/s41586-022-04480-z – volume: 162 start-page: 743 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib27 article-title: Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.11.006 – volume: 55 start-page: 1159 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib220 article-title: Pathways of liver injury in alcoholic liver disease publication-title: J. Hepatol. doi: 10.1016/j.jhep.2011.05.015 – volume: 22 start-page: 228 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib230 article-title: Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.07.009 – volume: 12 start-page: 17 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib170 article-title: Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features publication-title: Gut Liver doi: 10.5009/gnl16510 – volume: 146 start-page: 1513 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib199 article-title: Interactions between the intestinal microbiome and liver diseases publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.01.020 – volume: 73 start-page: 102 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib59 article-title: Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.01.011 – volume: 373 start-page: eabe6729 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib88 article-title: Enterically derived high-density lipoprotein restrains liver injury through the portal vein publication-title: Science doi: 10.1126/science.abe6729 – volume: 2 start-page: 1037 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib148 article-title: NGM282 for treatment of patients with primary biliary cholangitis: a multicenter, randomized, double-blind, placebo-controlled trial publication-title: Hepatol. Commun. doi: 10.1002/hep4.1209 – volume: 39 start-page: 587 year: 1996 ident: 10.1016/j.cmet.2022.09.017_bib38 article-title: Role of the gut in the pathophysiology of extrahepatic biliary obstruction publication-title: Gut doi: 10.1136/gut.39.4.587 – volume: 143 start-page: 1741 year: 2002 ident: 10.1016/j.cmet.2022.09.017_bib224 article-title: Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity publication-title: Endocrinology doi: 10.1210/endo.143.5.8850 – volume: 110 start-page: 9066 year: 2013 ident: 10.1016/j.cmet.2022.09.017_bib61 article-title: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1219451110 – volume: 39 start-page: 371 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib53 article-title: Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis publication-title: Liver Int. doi: 10.1111/liv.13979 – volume: 68 start-page: 234 year: 2018 ident: 10.1016/j.cmet.2022.09.017_bib15 article-title: Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort publication-title: Hepatology doi: 10.1002/hep.29791 – volume: 40 start-page: 111008 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib41 article-title: Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome publication-title: Cell Rep. doi: 10.1016/j.celrep.2022.111008 – volume: 160 start-page: 556 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib2 article-title: Chronic liver diseases and the microbiome-translating our knowledge of gut microbiota to management of chronic liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.10.056 – volume: 10 start-page: 3206 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib11 article-title: The pathophysiology of farnesoid X receptor (FXR) in the GI tract: inflammation, barrier function and innate immunity publication-title: Cells doi: 10.3390/cells10113206 – volume: 54 start-page: 91 year: 2005 ident: 10.1016/j.cmet.2022.09.017_bib139 article-title: PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis publication-title: Gut doi: 10.1136/gut.2004.046615 – volume: 18 start-page: 679 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib36 article-title: Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00452-2 – volume: 68 start-page: 1477 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib134 article-title: Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis publication-title: Gut doi: 10.1136/gutjnl-2018-316670 – volume: 11 start-page: 525 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib154 article-title: Dietary fructose alters the composition, localization, and metabolism of gut microbiota in association with worsening colitis publication-title: Cell. Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2020.09.008 – volume: 71 start-page: 1126 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib210 article-title: FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.06.017 – volume: 11 start-page: 2471 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib103 article-title: Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels publication-title: Nat. Commun. doi: 10.1038/s41467-020-16274-w – volume: 29 start-page: 408 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib28 article-title: A microbial metabolite remodels the gut-liver axis following bariatric surgery publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.12.004 – volume: 13 start-page: 874 year: 2022 ident: 10.1016/j.cmet.2022.09.017_bib34 article-title: IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence publication-title: Nat. Commun. doi: 10.1038/s41467-022-28478-3 – volume: 185 start-page: 409 year: 2015 ident: 10.1016/j.cmet.2022.09.017_bib242 article-title: The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats publication-title: Am. J. Pathol. doi: 10.1016/j.ajpath.2014.10.009 – volume: 114 start-page: 1071 year: 2019 ident: 10.1016/j.cmet.2022.09.017_bib9 article-title: Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial publication-title: Am. J. Gastroenterol. doi: 10.14309/ajg.0000000000000115 – volume: 64 start-page: 1049 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib235 article-title: Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.12.010 – volume: 282 start-page: 2085 year: 1998 ident: 10.1016/j.cmet.2022.09.017_bib179 article-title: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene publication-title: Science doi: 10.1126/science.282.5396.2085 – volume: 72 start-page: 470 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib25 article-title: Increased liver localization of lipopolysaccharides in human and experimental NAFLD publication-title: Hepatology doi: 10.1002/hep.31056 – volume: 31 start-page: 3848 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib121 article-title: Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human beta-defensin-1 and -2 secretion by colonic epithelial cells publication-title: FASEB J. doi: 10.1096/fj.201601365R – volume: 161 start-page: 1865 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib16 article-title: Prevalence of primary sclerosing cholangitis in patients With inflammatory bowel disease: a systematic review and meta-analysis publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.08.032 – volume: 23 start-page: 529 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib149 article-title: Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice publication-title: Neoplasia doi: 10.1016/j.neo.2021.04.004 – volume: 50 start-page: 90 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib81 article-title: Chylomicrons promote intestinal absorption of lipopolysaccharides publication-title: J. Lipid Res. doi: 10.1194/jlr.M800156-JLR200 – volume: 472 start-page: 57 year: 2011 ident: 10.1016/j.cmet.2022.09.017_bib247 article-title: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease publication-title: Nature doi: 10.1038/nature09922 – volume: 71 start-page: 2050 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib137 article-title: Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice publication-title: Hepatology doi: 10.1002/hep.30975 – volume: 59 start-page: 2286 year: 2014 ident: 10.1016/j.cmet.2022.09.017_bib241 article-title: Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats publication-title: Hepatology doi: 10.1002/hep.26939 – volume: 24 start-page: 15 year: 2016 ident: 10.1016/j.cmet.2022.09.017_bib56 article-title: The cardiovascular biology of glucagon-like peptide-1 publication-title: Cell Metab. doi: 10.1016/j.cmet.2016.06.009 – volume: 5 start-page: 1507 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib256 article-title: Obeticholic acid decreases intestinal content of Enterococcus in rats with cirrhosis and ascites publication-title: Hepatol. Commun. doi: 10.1002/hep4.1740 – volume: 31 start-page: 25 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib68 article-title: Intersection of the gut microbiome and circadian rhythms in metabolism publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2019.08.013 – volume: 136 start-page: 1435 year: 2009 ident: 10.1016/j.cmet.2022.09.017_bib39 article-title: Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.12.040 – volume: 23 start-page: 107 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib178 article-title: A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice publication-title: Nat. Med. doi: 10.1038/nm.4236 – volume: 158 start-page: 1948 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib191 article-title: Circadian rhythms in the pathogenesis and treatment of fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.01.050 – volume: 38 start-page: 2948 year: 2017 ident: 10.1016/j.cmet.2022.09.017_bib196 article-title: Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehx342 – volume: 160 start-page: 1784 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib119 article-title: Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.12.058 – volume: 384 start-page: 1113 year: 2021 ident: 10.1016/j.cmet.2022.09.017_bib164 article-title: A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2028395 – volume: 159 start-page: 1807 year: 2020 ident: 10.1016/j.cmet.2022.09.017_bib86 article-title: High-throughput screen identifies host and microbiota regulators of intestinal barrier function publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.07.003 |
| SSID | ssj0036393 |
| Score | 2.7226346 |
| SecondaryResourceType | review_article |
| Snippet | Bidirectional crosstalk along the gut-liver axis controls gastrointestinal health and disease and exploits environmental and host mediators. Nutrients,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1700 |
| SubjectTerms | Gastrointestinal Microbiome - physiology gut microbiome gut-liver axis Humans Inflammation - metabolism leaky gut Liver - metabolism Liver Cirrhosis - metabolism liver disease Non-alcoholic Fatty Liver Disease - metabolism |
| Title | Gut-liver axis: Pathophysiological concepts and clinical implications |
| URI | https://dx.doi.org/10.1016/j.cmet.2022.09.017 https://www.ncbi.nlm.nih.gov/pubmed/36208625 https://www.proquest.com/docview/2723160075 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA6lIHgR39YXK3iT0G2yj8SbltYiKIIWegvJJgsrdVvsFvTfO7OPoqA9eNxlwoYv2ZlvknkQcpk6m8amx6mJWEwDG2lqXGioAyqbCumA0uLRwMNjNBoH95Nw0iL9JhcGwypr3V_p9FJb12-6NZrdeZZ1n5FcgwruMVxoP8aMch6IMolvcttoYw4WuAyyB2GK0nXiTBXjlbw5jKdkrKx1WjYt-9U4_UU-SyM03CZbNXv0bqoJ7pCWy3fJRtVP8nOPDO6WBZ1ipIWnP7LFtfcE_G5WHl40Os5LqjzFhadz6zV5kV72LbB8n4yHg5f-iNZ9EmgSMFZQKWwKXoyLYFdIGSdM8yTmUoCrkwIiALsVvkx9nogUK8CBuNYmlUwzcGiSiB-Qdj7L3RHxpDDORr4ROmKB04HkHFyi0CCt08LaDuk1AKmkLiKOvSymqokWe1UIqkJQlS8VgNohV6sx86qExlrpsMFd_dgICnT82nEXzSIp-EPw2kPnbrZcKBYDh8Uy_GGHHFart5oHmG_06cLjf371hGziU5WceEraxfvSnQFLKcx5uQ2_AOZN4-8 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxsxEB5RUNVeKqAtpIXWSO0JWdnY-7CROACFJrxUCZByM_auV0qVblCTqM3v6h9kZh8RSIUDEtfd9a71jT3zjXceAF9yn-WJ60juYpHwMIstdz5y3COVzZX2SGnpaODsPO5ehcf9qL8A_5pcGAqrrHV_pdNLbV1faddotm8Gg_YFkWtUwR1Bgg6SpI6sPPGzP-i3jXd731DIX4U4Orw86PK6tQBPQyEmXKssR-LvYwRS6yQVVqaJ1Aq9g1yGCmeaqUDngUxVTkXT8HFrXa6FFegDpLHE976AJWQfCWmDXn-_Uf8STX4Z1Y-z4zS9OlOnCipLf3kK4BSiLK5adkn7rzV8iO2WVu9oGd7UdJXtVYiswIIvVuFl1cBy9hYOv08nfEihHcz-HYx32A8klKPytKRRqiytEiPHzBYZaxIx2eBOJPs7uHoW9N7DYjEq_DowrZzP4sApG4vQ21BLiT5Y5IhHWpVlLeg0AJm0rlpOzTOGpglP-2kIVEOgmkAbBLUF2_MxN1XNjkefjhrczb2VZ9CoPDpuqxGSwS1J_1ls4UfTsREJkmaq-x-1YK2S3nweyBfIiYw-PPGrn-FV9_Ls1Jz2zk8-wmu6U2VGbsDi5PfUbyJFmrhP5ZJkcP3ce-AWX1wg3A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut-liver+axis%3A+Pathophysiological+concepts+and+clinical+implications&rft.jtitle=Cell+metabolism&rft.au=Tilg%2C+Herbert&rft.au=Adolph%2C+Timon+E.&rft.au=Trauner%2C+Michael&rft.date=2022-11-01&rft.issn=1550-4131&rft.volume=34&rft.issue=11&rft.spage=1700&rft.epage=1718&rft_id=info:doi/10.1016%2Fj.cmet.2022.09.017&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_cmet_2022_09_017 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-4131&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-4131&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-4131&client=summon |